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Preface 
The scope of this thesis is a structural investigation of the Hydra nematocyst capsule 
wall on the molecular level along with few steps forward in order to understand its 
assembly mechanism. The nematocyst is a unique organelle of the nematocytes, a 
special cell type of all Cnidarians. The nematocyst serves the functions of prey 
capture and defense in Hydra, jellyfish, corals, and other Cnidarians. It exhibits one 
of the fastest known cellular processes by its exocytosis (1). The nematocyst was 
studied in many different ways during the past four decades (1-15). The complexity of 
functions, assembly, and structure makes it a very intriguing object for zoologists, cell 
biologists and structural biologists. The capsule wall of this organelle persists very 
high osmotic pressures of about 150 bars gained by poly-?-glutamic acid (3), being at 
the same time very elastic as it changes its volume considerably during discharge. 
This poses the problem of how a structure of sufficient stability may be assembled.  
There were several steps already made in order to reveal the structure of the 
nematocyst wall. The aims of the present thesis were to extend the existing 
knowledge and recognize the structural basis of the nematocyst wall on the 
molecular level. Two proteins have been identified as major components of the wall: 
minicollagens (16) and NOWA (13). These proteins were found to compose recently 
identified structural building block of the nematocyst capsule wall termed 
“capsulomer” (17). Chapter 1 of the thesis is dedicated to the investigation of 
recombinant NOWA assembly and clustering that provides few insights into certain 
events of nematocyst morphogenesis. A permanent player of the nematocyst 
development and functioning is a membrane of Golgi vesicle. Previously made in vivo 
observations indicating close relations of the nematocyst and membrane (18,19) 
were accomplished by the in vitro studies of NOWA – membrane interaction in this 
thesis (see “Chapter 2”). Minicollagen and NOWA exhibit special domain organization 
sharing the Cys–rich domains which are meant to be used for intermolecular disulfide 
reshuffling. The minicollagens found in nematocysts are the shortest collagens 
currently known. The presence of the cysteine rich domains at both sides of the 
collagen molecule implies the ability to undergo the disulfide isomerization in order to 
accomplish regular collagen network elasticity by the very high strength. From the 
other hand NOWA, that has eight times repeated cysteine rich domain with the 
cysteine pattern identical to that in mini-collagen, has to be fitted to the collagen 
 2 
network. Three-dimensional structure of this particular domain, which is presumably 
the most important feature of the nematocyst wall assembly, provides an insight into 
a mechanism of this assembly and reveals an interesting example of unusual cystine 
stabilized fold (see Chapter 3 and Chapter 4).  
The overall organization of the nematocyst capsule wall serves us with a general 
model of the structures of very high tensile strength and provides with an excellent 
naturally designed tool for advanced materials elaboration.  
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Summary 
 
The present thesis includes four parts. All of them are devoted to the 
investigation of the nematocyst capsule wall structure and assembly. The nematocyst 
wall is unique in its resistance to high pressures accomplished by a pronounced 
elasticity. The capsule develops inside a Golgi vesicle using the vesicular membrane 
as a substrate. Recent studies demonstrated that the mature nematocyst capsule 
wall is a compact structure of several closely arranged layers of globular building 
units termed “capsulomers”. These globules have slightly heterogeneous size 
distribution of 20 nm average diameter. Capsulomers were shown to be 
heterooligomers of NOWA and minicollagens which are crosslinked by disulfide 
bonds. In addition capsulomer precursors composed of NOWA alone were identified 
at the certain step of the nematocyst capsule development.  
Minicollagens and NOWA share similar cysteine rich domain that is presumably 
responsible for the disulfide dependent capsulomer formation and further covalent 
cross-linking of the capsulomers. However exact mechanism of the highly ordered 
intra- to inter- disulfide isomerization leading to the formation of the capsule wall 
remains unclear. The structure of the common cysteine rich domain was not known 
also.  
(Chapter 1) In order to investigate whether NOWA alone assembles to 
capsulomer-like structures the full-length protein was expressed in mammalian cells, 
purified and investigated by various techniques. Mammalian expression system was 
chosen to provide post-translational modifications of the protein and correct disulfide 
connectivity. Monomeric and oligomeric fractions of the recombinantly expressed 
protein were isolated and studied by transmission electron microscopy. NOWA 
monomers revealed compact globular structures. Oligomeric fraction of protein was 
found to be self-assembled capsulomer- like globules of the average diameter similar 
to that of native wall capsulomers. The capsulomer-like structures have melted upon 
reduction. Similar experiments were performed with the recombinantly expressed 
NOWA fragment containing eight Cys-rich domains (ONCRD). This construct was 
shown to assemble into ring-like structures rather than spherical particles. Small ring-
like structures were further associated in chains of different curvature. Thus assembly 
of the recombinant NOWA to capsulomer-like structures was concluded to be a 
feature of its cysteine rich domain although other protein domains needed to provide 
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a control of disulfide isomerization. Furthermore capsulomer-like structures exhibited 
calcium dependent clusterization. This property of the recombinant protein was 
discussed to explain natural behavior of the capsulomer precursors during 
nematocyst development. 
(Chapter 2) Nematocyst wall maintains close contact with the membrane of the 
Golgi vesicle during capsule development as well as in mature form. To investigate 
whether NOWA is able to interact with the membrane surfaces recombinantly 
expressed protein was studied by several techniques. NOWA binding to the model 
lipid monolayers and bilayers was directly visualized by electron microscopy. Surface 
plasmon resonance kinetic studies revealed high affinity of the capsulomer-like 
structures to the negatively charged surface of lipid bilayer (KD~ 100 nM). Calcium 
induced clusters of the NOWA capsulomers exhibited ten times lower membrane 
affinity. This provides an explanation for in vivo dissociation of the capsulomer 
precursor clusters. Two parts of NOWA involved in the membrane binding were 
identified: C-type lectin domain and basic C-terminal sequence. The cysteine rich 
domain of the protein had shown no membrane affinity. 
(Chapter 3) The minicollagen and NOWA cysteine-rich domains (MCRDs and 
NCRDs respectively) are believed to function in a switch of the disulfide connectivity 
from intra- to intermolecular bonds during maturation of the capsule wall. The N- and 
the C-terminal MCRDs as well as 8 cysteine rich domains of NOWA are homologous 
and share the cysteine pattern CXXX(X3)CXXXCXPXCXXXCC. The peptide 
comprising the last 24 residues of the minicollagen-1 was produced synthetically and 
successfully refolded by oxidation under low protein concentration. The solution 
structure of the C-terminal MCRD was determined by 1H NMR technique. Disulfide 
connections Cys2-Cys18, Cys6-Cys14, Cys10-Cys19 were found that constrained 
the structure into a compact new fold.  
(Chapter 4) The solution structure of the first cysteine rich domain of Hydra 
nematocyst wall protein NOWA (NCRD1) has been determined using homonuclear 
and heteronuclear NMR techniques at natural abundance. The elucidated peptide 
composing 25 amino acids was produced synthetically and oxidized. The NCRD1 
has revealed the disulfide pattern identical to that of the MCRD. Moreover NOWA 
domain exhibited overall structure topology similar to the topology of minicollagen 
domain structure. Despite the differences in the N-terminal structures two peptides 
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revealed the same structural fold defined by conserved cysteines connection and ß-
turns. 
The MCRD and NCRD1 both have single tyrosine in their sequences. Tyrosine 
fluorescence quenching by disulfide bonds was observed in both peptides. The 
oxidative refolding of MCRD and NCRD1 has been monitored by tyrosine 
fluorescence. Resulting kinetics were fitted with mono-exponentials suggesting a 
simple kinetic mechanism that arises from the quenching by only one particular 
disulfide bond in each case. The Cys2-Cys18 bond in case of MCRD and Cys6-
Cys14 in case of NCRD1 are discussed to be responsible for fluorescence quenching 
effect. Oxidative refolding rate constants related to the formation of indicated bonds 
were determined. 
 
 
 
 7
 
 
 
 
 
General Introduction  
Part 1 
 
 
Nematocysts of Cnidarians 
Morphogenesis of the nematocyst capsule 
 8
General Introduction 
Nematocyst Morphology  
Nematocysts are one of the cnidae (2-4) which are highly specialized, secretory, 
subcellular organelles serving as offensive and defensive structures (5) typical of 
cnidarians. Remarkable in their structural and functional complexity, nematocysts 
serve as a fascinating model for different research directions. Cnidae have been 
distinguished into three broad classes: nematocysts, spirocysts and ptychocysts 
(6). Spirocysts and ptychocysts are found only in anthozoans (7-11). 
Nematocysts are found in hydroids, jellyfish, sea anemones, and corals. The 
presented thesis is focused on the nematocysts of Hydra. Mature nematocysts 
are primarily localized in tentacles but precursor forms are found mounted in 
ectodermal epithelial cells throughout the animal. A large number of different 
morphological types of nematocyst capsules are found within the Cnidaria. 
Individual species, however, have only a small number of different nematocyst 
types. The fresh water polyp Hydra vulgaris has four morphological types of 
nematocysts: stenoteles, desmonemes, atrichous and holotrichous isorhizas. 
Morphological differences among these types are easily noticed from the figures 
1, 2, and 3. 
 
  
 
 
 
 
 
 
Figure 1. 
Desmonemes of Hydra. Schematic representation (A) and light microscopy 
pictures of the intact and discharged capsule (B). 
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Figures 1, 2 are adapted from (5). Fig.3 is from (12). 
This study is focused on the structural assembly of the Hydra nematocyst 
capsule. All capsule-related experiments described below were performed 
preferentially with the stenoteles of Hydra vulgaris. Nematocyst capsules are 
formed in clusters of differentiating nematocytes (13) in the body column of Hydra 
polyps. Once capsule differentation is completed these clusters break up into 
single cells that migrate to tentacles and become mounted in specialized tentacle 
epithelial cells, called battery cells (Fig.4). One nematocyst capsule is formed per 
cell in a differentiating nematocyte (14). 
Figure 3. 
Atrichous and holotrichous isorhizas. Schematic representation (A) and 
electron microscopy picture of the intact capsule (B).  
Figure 2. 
Stenotele of Hydra. 
Electron microscopy 
picture of the intact 
capsule (A), bar is 
5µm.  
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Extensive EM investigations have documented the morphology and differentiation 
of capsules (15). Capsules have a strong outer wall surrounding an inverted 
tubule. 
Nematocyst ultrafast exocytosys. 
It has been realized for over 10 years ago that a high internal osmotic pressure 
develops inside the nematocyst capsule by the synthesis of poly-?-glutamate at 
the late stages of capsule development (1, 16). The maximum pressure reaches 
150 atmospheres which is unusually high for biological systems. The ability of the 
capsule to withstand such pressure immediately poses the intriguing question for 
its molecular composition and assembly. The present thesis work is devoted to 
this question.  
The time course of the rapid process of nematocyst discharge has been 
visualized in Hydra vulgaris by Holstein and Tardent in 1984 (17). Discharge was 
triggered by an extracellular electrical stimulus. Using high-speed 
microcinematography, an initial increase of the stenotele volume (phase a) can 
be demonstrated during the interval between the onset of the electrical stimulus 
and the opening of the operculum. After about 100 µs the capsule's cover is 
Figure 4. 
Morphology of the nematocyst (A). 
Hydra body plan (B).  
A B 
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opened and the stylets are ejected in less than 10 µs (phase b). Discharge is 
then arrested for approximately 150 µs (phase c), presumably in order to allow 
withdrawal of the stylets from the opening created in the prey's integument. Then 
the long (0.5 mm) and slender (0.8 µm) tubule evaginates at a velocity of about 
0.3 m/s into the prey's body. Figure 5 shows a schematic representation of the 
events during nematocyst exocytosis as a function of time.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
The figure is adapted from Tardent et.al.(18). 
Figure 5 
Schematic representation of the stenotele nematocyst discharge as a function 
of time. Five discrete phases are indicated: a, b, c, d and e. In phase “a” the 
nematocyst capsule is intact but dramatic decrease of body volume is 
observed. In phase “b” operculum opens (OP) and stylet (STY) with shaft 
(SHA) and lamellae (LA) is ejected. The tubule (TUB) is still inside the 
capsule. CWA indicates capsule wall. Phase “c” is a retention phase when 
capsule volume slowly decreases. In phase “d” stylets open and discharge 
observed. Phase “e” represents continuous discharge when tubule is 
completely exerted. Time scale is indicated on the low part of the figure. CNC 
is cnidocil. 
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Nematocyst morphogenesis 
The nematocyst is produced during a highly ordered secretion and 
assembly process of proteins inside a giant post-Golgi vesicle of the 
nematocytes (19). Nematocyst morphogenesis can be subdivided into five stages 
(15): 
1. An early growth phase during which the capsule primordium forms and grows 
by addition of new vesicles to the vesicle harboring the capsule.  
2.  A late growth phase during which a tubule forms outside the capsule by 
addition of more vesicles; capsule and tubule wall form a continuous 
structure.  
3.  Invagination of the long external tubule into the capsule.  
4.  An early maturation phase leading to the formation of spines by 
condensation of the protein spinalin (20) inside the invaginated tubule.  
5.  A final late maturation step during which poly- -glutamate is synthesized in 
the matrix of the capsule (1). At this point the wall structure `hardens' (i.e. is 
no longer deformed when tissue is fixed) and the capsule swells to its final 
size.  
Two proteins have been identified as major constituents of the nematocyst 
capsule wall: NOWA (Nematocyst Outer Wall Antigen) (21) and mini-collagens 
(22). Mini-collagens are a family of unusually short collagens (22). They comprise 
a central collagen triple helix with 12-16 Gly-X-Y repeats flanked by polyproline 
stretches and terminal cysteine-rich domains (MCRDs). Minicollagens are 
trimeric molecules that are expressed as soluble precursors, which during 
nematocyst maturation polymerize probably by a switch in the disulfide linkage 
from intra- to intermolecular connections (19). This process is accompanied by a 
loss of minicollagen antibody reactivity in the head and tentacles regions of 
Hydra in mature nematocysts (19). 
NOWA is a 90 kDa glycoprotein that has been described to be associated 
with the globular structure of the nematocyst outer surface (21). Interestingly, the 
molecular architecture of NOWA comprises a C-terminal octad repeat of a 
cysteine-rich domain homologous to that of minicollagen, suggesting a disulfide-
dependent heteroassembly of minicollagens and NOWA. These two proteins are 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 
Scheme is originally adapted from Engel et.al (23) and has been modified according to the recent 
findings. Formation of the nematocyst capsule wall from Nowa (green) and minicollagen (red). (A) 
Protein sorting and transport as detected by minicollagen antibody and mAb H22, Ab MCCR; Ab 
CTLD and Ab. Minicollagen and Nowa synthesized in the ER are transported in separate vesicles to 
the nematocyst vesicle. Nowa is detected by three antibodies: mAb H22 (against glycosylation), Ab 
CTLD and Ab MCCR. MTs (yellow) are organized in a scaffold around the growing part of the 
nematocyst, the MTOC is localized between the Golgi apparatus and the growing apex of the 
nematocyst. Minicollagen first accumulates in the capsule matrix and is then sorted to the wall to form 
the wall together with NOWA (3). By further transport of protein-filled vesicles, the outer tubule forms 
(4). It is subsequently invaginated into the cyst, and spines (s) are formed in the tubule lumen (5). 
Finally, minicollagen crosslinkage leads to a compaction of the wall structure (6). (B) Model of 
nematocyst patterning by the MT cytoskeleton. The growing part of the nematocyst vesicle is shown 
in a schematic cross-section. MTs form a cage around the vesicle and determine its shape (1). The 
initial stage includes binding of NOWA to the membrane. At the same time NOWA accumulates 
inside the capsule (2). Membrane bound NOWA is used as template for minicollagen assembly. 
Soluble minicollagen trimers aggregate on the outer wall to continue formation of the wall (3-5) via 
intermolecular disulfide crosslinking. Finally Nowa and minicollagen are crosslinked by disulfide 
bonds to stabilize the structure (6). 
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expressed at the early stages of t he nematocyst development. The general 
scheme of the nematocyst morphogenesis includes five described stages and 
detailed view of the wall assembly from NOWA and minicollagen is represented 
in Fig.6.  
It has been described previously that the nematocyst capsule wall is 
composed of two distinct layers. NOWA was associated with the outer layer 
when mini-collagen was thought to compose a dense and elastic “inner” wall. 
These observations have been made by Holstein et al. using atomic force 
microscopy (17). Immunofluorescence analysis of the developing nematocyst 
capsule is consistent with a two-layer structure although immunofluorescent 
staining has only limited resolution (19). The immunostaining analysis has been 
done using the antibodies raised against glycosylated NOWA and the one 
against recombinantly expressed mini-collagen-1. The data clearly demonstrated 
a two layered structure of the wall. However, recent ultrastructural investigation 
of the ruptured capsule using scanning electron microscopy (23) suggests a 
uniform composition of the wall with a density gradient decreasing from the inner 
to the outer side. To visualize the fine structure of the nematocyst wall in profile 
isolated non-discharged capsules were sonicated to induce wall ruptures. 
Scanning electron microscopy (SEM) was then performed with carbon or 
platinum-covered samples fixed on glass covers. Most of the nematocysts were 
still intact after a short (2 minutes) ultrasound treatment but several showed a 
rupture predominantly perpendicular to the length axis of the capsule body where 
the tubule had then discharged without eversion. Figure 7A shows a total view of 
a stenotele displaying a typical rupture. The operculum at its narrow end, which 
opens to release the tubule when nematocyst discharge is triggered, is still 
closed and the stylet apparatus used for puncturing the cuticle of a prey 
organism is folded back inside the capsule body and wrapped by the base of the 
tubule. A high resolution imaging of the wall surfaces by platinum covering 
revealed a composition of the wall profile consisting of several layers (6-7) of the 
globular building units termed capsulomers (Fig. 7B). The thickness of the wall is 
about 150 nm and in contrast to the two-layer model a homogeneous globular 
appearance throughout the whole cross-section was observed. The two-layer 
appearance observed earlier can be explained by the density gradient from the 
outer to the inner side of the wall. Immunofluorescence studies (24) performed 
 
 
Figure 7. 
Field Emission Scanning Electron Microscopy (FESEM) analysis of sonicated 
capsules with carbon (A) or platinum shadowing (B). A, Total view of a stenotele with 
a characteristic wall rupture induced by ultrasound treatment. Bar = 3 ?m. B, Profile 
of ruptured wall shown at high magnification. Bar = 100 nm. Figure is adapted from 
Özbek et.al. 
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with the antibodies against different domains of NOWA changes the picture of 
the NOWA appearance and localization during capsule development that was 
reported before (19). On the Fig. 8A developing nematocyst capsules are stained 
with three different antibodies: Anti-NOWA-ONCRD (raised against 8 folded 
cysteine rich domain), Anti-NOWA- CTLD (raised against C-type lectin domain) 
and Anti-H22 (raised against NOWA). It is obvious from the figures that 
localization of NOWA restricted to the wall is only observable by the anti-H22. 
The polyclonal antibodies raised against recombinantly expressed NOWA 
domains show identical staining of NOWA accumulated in huge aggregates 
inside the capsule. Thin section electron microscopy of the developing 
nematocyst shows that inside NOWA aggregates are composed of globular 
particles (Fig. 8B). These globules are precursors of the capsulomers and only 
contain NOWA. Staining with minicollagen antibody at this stage of the 
nematocyst development showed diffused homogeneous pattern throughout the 
capsule. Colocalization of NOWA and minicollagen staning unambiguously 
showed that compact globular appearances in the matrix contain exclusively 
NOWA protein (24). This observation is in agreement with the in vitro study of 
NOWA self-association and subsequent aggregation (see results of chapter 1). 
Upon maturation of the capsule the conglomerates melt or dissociate but no wall 
staining appears. In the mature nematocyst both NOWA domain antibodies only 
stain invaginated tubule when anti-H22 still stains the outer side of the capsule 
wall. Scanning electron microscopy analysis shows that the tubule is uniformly 
covered by loosely attached capsulomers (23). The following hypothesis can be 
proposed to explain such differences in staining patterns. One can assume that 
two types of NOWA protein exist. These types differ in a way of post-translational 
modifications. In this frame one type of NOWA is expressed as a soluble material 
and positioned directly on the membrane forming so called outer wall. The wall-
related staining pattern observed with the H22 antibody is must therefore be 
assigned to this form of NOWA. Another form of the protein, most probably 
lacking some glycosylation, is initially accumulated in the capsule body as 
described above. These conglomerates melt at a certain point and dissociate 
towards the wall in a form of single globular particles. The absence of wall 
staining pattern with antibodies against NOWA domains is most probably due to 
the high compactness of the wall at this time. The dissociation of NOWA from 
                                     
 
 
Figure 8. 
A, Immunofluorescent staining of developing nematocyst capsules using three 
different antibodies: Anti-NOWA-MCCR (raised against 8 fold cysteine rich domain), 
Anti-NOWA-CTLD (raised against C-type lectin domain) and Anti-H22 (raised 
against glycosylated NOWA). B, Transmission electron microscopy picture thin 
section of the developing capsule. Red arrows indicate globular particles identified 
as NOWA conglomerates. Bar indicated on the upper panel is 5 µm. C, 
Immunofluorescent staining of the late stage nematocyst development (Anti-NOWA-
MCCR). Only invaginated wrapped tubule is stained. Bar is 5 µm. The data are 
adapted from the Diploma work thesis of Wurm C. 
 
A 
B C 
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conglomerates to smaller units is most probably governed by Ca2+ ions. Poly-?-
glutamate (PG) synthesis startes in a late stage of nematocyst development after 
invagination of the external tubule (1). At the same time the staining for NOWA 
aggregates vanishes and the invaginated tubule is stained instead. It is known 
that poly- ? -glutamate binds calcium ions. Therefore parallel to the appearance 
of the PG the amount of calcium is supposed to decrease that leads to the 
dissociation of NOWA conglomerates to single capsulomers which associate with 
the wall. Calcium dependent aggregation of self-assembled recombinantly 
expressed NOWA will be demonstrated and discussed later in chapter 1.  
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Domain organization of NOWA and minicollagen. 
 
As already mentioned two proteins composing a structure of the nematocyst 
capsule wall, NOWA (5) and minicollagen (7) have been identified. These proteins of 
completely different size and presumably different structural organization are 
suggested to form elastic and strong capsule wall via intermolecular disulfide 
isomerization.  
Minicollagens of Hydra nematocysts are the shortest collagens known and at 
the same time are unique due to their unusual domain organization. The domain 
organization of the minicollagen molecule discussed by Engel et al (9) is presented in 
figure 1. 
 
 
 
 
 
 
 
 
 
The SMART database identifies two domains in the 90 kDa NOWA sequence: 
SCP and CTLD (Fig.2).  
 
             NOWA domains 
 
 
 
 
 
 
SCP (Sperm Coating Protein) domain found in the extracellular protein family. 
Human glioma pathogenesis-related protein GliPR and the plant pathogenesis-
related protein both containing SCP domains represent functional links between plant 
Figure 1. 
Schematic representation of 
minicollagen domains. Yellow 
circles are the cysteine rich 
domains, which is a unique 
feature of nematocyst 
minicollagens. 
Cys-rich domain
Polyhydroxiproline
Collagen sequence
Minicollagen 
Figure 2. 
NOWA domain organization 
identified by SMART and by 
homology to the minicollagen 
Cys-rich domain (yellow 
circles) 
CTLDSCP
Polyhydroxyproline 
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defense systems and human immune system. The function as well as 3D fold are not 
known for this domain.  
The C-type lectin domain (CTLD) is found in many different proteins 
predominantly but not exclusively in vertebrates. Many of these domains function as 
calcium-dependent carbohydrate binding modules. C-type-lectin-like domains were 
first identified as 110-140-residue-long carbohydrate recognition domains (CRDs) of 
group C of animal lectins, which bound carbohydrates in a Ca2+-dependent manner 
(11). By comparing sequences of C-type lectins, a set of conserved positions was 
identified, which includes residues involved in Ca2+- and carbohydrate-binding, and 
fold integrity maintenance (11, 13). Known CTLD structures exhibit significant 
structural conservation despite the low seguence similarities. Structurally, CTLDs 
were divided into two groups: canonical CTLDs having a long loop region, and 
compact CTLDs that lack it (4). Conserved structural folds for canonical and compact 
C-type lectins are shown on figure 3. 
 
 
 
 
 
 
 
 
 
 
Figure 3 
Ribbon diagrams of (a) compact (intimin, 1f00) and (b) canonical (E-selectin, 
1g1t) CTLD structures. The long loop region in E-selectin, and the short -
helix that replaces the LLR in compact CTLDs, are shown in black. 
Secondary structure labels are according to the secondary structure element 
(SSE) naming scheme. This figure is adapted from Zelensky et. al. (4). 
 
 20
Besides the SCP and CTLD domains NOWA has eight cysteine-rich repeats 
similar to the two in minicollagen first described in (5). These repeats start after the 
CTLD and are followed by a basic C-terminal sequence. The presence of an identical 
cysteine pattern in these two proteins suggests a possibility to reshuffle disulfides 
from intra to intermolecular bonds during formation of the nematocyst capsule wall. 
Therefore covalently cross-linked wall structure can supply unusually high tensile 
stress resistance. It was demonstrated that minicollagen trimers are not covalently 
cross-linked. Consequently all disulfides must be closed within the domain (9). The 
cysteine-rich domain in minicollagen and NOWA has an unusual cysteine pattern 
which could not be assigned to any consensus pattern identified in known cysteine-
rich domains. This poses the questions for cysteine connectivity and 3-D structure of 
this domain. Also an interesting problem is whether the separated Cys-rich domain is 
able to fold independently. In the present theses I have approached indicated 
problems and found that minicollagen and NOWA cysteine rich domains fold 
independently into a compact structure stabilized by disulfide bonds, which is in fact a 
new structural fold (see Chapter 3 and Chapter 4). Below a summary of the structural 
variety of the currently known cysteine-rich peptides is presented. 
 
Disulfide dependent protein folding pathways. 
Native disulfide bond formation is crucial for the proper folding of many proteins. 
Disulfide bond formation and formation of non-covalent interactions are coupled 
significantly during conversion of a conformationally unstable precursor to the stable 
native product. Two mechanisms for oxidative folding are described for monomeric 
proteins. In the folded-precursor mechanism, the precursor species first folds non-
covalently into a state in which reactive thiol- groups are correctly positioned for the 
formation of native disulfide bonds. In contrast, in the quasi-stochastic mechanism, 
the disulfide formation occurs quasi-stochastically, i.e. reactive thiol groups encounter 
each other with a probability determined primarily by loop entropy, albeit modified by 
conformational biases in the unfolded state. In this case the incorrectly established 
disulfide bonds need to be reshuffled. It has been demonstrated that the quasi-
stochastic mechanism is more plausible than the folded-precursor mechanism for 
most globular proteins (14). Oxidative folding of the minicollagen and NOWA cysteine 
rich domains is discussed in chapter 4.  
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Independently folded cysteine rich domains of proteins and bioactive cysteine 
rich peptides are of large structural and functional variety. It is difficult to classify them 
according to their cysteine patterns or three-dimensional structural folds. 
Nevertheless few classes could be identified.  
 
Cystine knots containing growth factors family. 
First of all cystine knots have to be described. These are fascinating structural 
motifs in which an embedded ring formed by two disulfide bonds and their connecting 
backbone segments is threaded by a third disulfide bond. Three related cysteine knot 
containing families are distinguished today: growth factor cystine knots (GFCKs), 
inhibitor cystine knots (ICKs), and cyclic cystine knots (CCKs) (15). Few structural 
examples for each type of cystine knot will be given in the scope of this introduction.  
Polypeptide growth factors, a diverse group of regulatory agents, that controls cell 
survival, proliferation and differentiation. The determination of the crystal structure of 
dimeric Nerve Growth Factor (NGF) revealed a novel three-dimensional fold. Each 
subunit consist of predominantly ß-strand secondary structure and an unusual 
clustering of three disulfide bridges (2).  
 
 
 
 
 
 
 
 
 
Subsequently the structure of TGF ß2 showed a tertiary fold similar to NGF. This 
observation has been confirmed by a structural comparison of the NGF and TGF ß2 
molecules (1, 16-18). The structure of platelet derived growth factor (PDGF-BB) has 
provided another example of this structural fold (19). 
 
Figure 4. 
Structure of the NGF monomer (2).  
Figure 5.  
Structure of the TGF ß2 monomer (1). 
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Figure 6. Crystal structure of the platelet derived growth factor BB dimer. 
 
The six half-cystines are virtually the only conserved feature evident from the 
structural sequence alignment of NGF and TGF ß2. The long-range disulfide bond 
formation observed for this class of proteins and their consensus cysteine pattern can 
be represented by only four cysteines as CXmC / CXC, where m is variable for 
different proteins. A general cystine knot containing growth factor fold is summarized 
by the scheme represented on figure 7. 
 
 
 Figure 7. 
 General scheme representing a cystine knot containing 
growth factor super-family structural fold. Here V1, V2, V3 
represent any structural feature. Cysteines connections 
indicated by white curves. The squared Xs indicate any 
amino acid in between the consensus cysteines.  
 
 
 
Inhibitor cystine knots family or “knottins”. 
A second family of the cystine knot containing proteins is inhibitor cystine knots 
family or “knottins”. The name “inhibitor cystine knot” has been introduced long time 
ago when the first knottins were identified. The first “knottins” were the potato 
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carboxypeptidase A inhibitor, the structure of which was solved already in 1982 (20) 
and the trypsin inhibitor identified in 1989 (21). Over the last two decades many other 
proteins were recognized as knottins. A previously mentioned third class of cystine 
knots, cyclic cystine knots, can be generally classified as knottins as well. They are 
separated into a distinct type only because of the cyclic backbone. All other 
sequential and structural features are preserved for this type of proteins. In the scope 
of this introduction cyclotides are considered as a member of knottins structural 
family. Currently the knottin structural family includes several unrelated functional 
protein families: 
- Protease inhibitors from plants (trypsin inhibitors are the most abundant) 
- Peptides from the Rubiaceae and the Violaceae plant families 
- Toxins from cone snail, spider, bug, crab, scorpion  
- Gurmarin-like peptides, human Agouti-related protein 
- Antimicrobial peptides 
Figure 8 shows representative 3-D structures of the proteins from each family. 
 
 
 
 
 
Figure 8. 
Members of the Knottins 
structural family: A, a-amylase 
inhibitor from amaranth (1QFD) 
(3); B, cyclotide Kalata B1 
(1K48) (6); C, insecticidal 
neurotoxin J-ACTX-Hv1c 
(1HP3) (8); D, gurmarin, a 
sweet-taste-suppressing plant 
polypeptide (1C4E) (10); E, 
tachystatin A, antimicrobial 
peptide (1CIX) (12). Each of 
these peptides represents a 
particular protein family as 
indicated above. 
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It becomes clear already from simple comparison of the structures that all these 
peptides constitute a structural family characterized by a number of ß – strands 
connected by loops and stabilized to a compact tight structure by the cystine knot.  
All “knottins” are found to be very stable but the most fascinating examples of 
stability are cyclotides. These peptides have an average unfolding temperature of 
100o C and higher (22). However it has been noticed that knottins, that contain at 
least three disulfide bridges, are possibly built from an ancestral two-disulfide 
elementary motif. This motif has been termed the CSB (Cystine Stabilized ß-sheet) 
motif (23). Figure 9 represents CSB elementary motif and the knottin structure built 
on its basis. 
 
 
 
Figure 9. Cystine Stabilized ß-sheet motif (right model) and knottin (left). 
 
General classification of knottins is considered to be as following:  
?? The knot implies that knottins contain at least 3 disulfide bridges;  
?? The structural family of knottins has the disulfide between cysteines III and VI 
going through disulfides I-IV and II-V; 
 25
?? Cysteine IV is special because it is either adjacent to cysteine III (e.g. in spider 
toxins) or two positions before CYS V (e.g; in protease inhibitors), or three 
positions before CYS V in PCI.  
A comparison of the knottins and the cystine knot containing growth factors is 
shown schematically in the figure 10.  
 
 
 
 
Figure 10. 
Schematic comparison of the Knottins and Growth Factor Family. Both families have 
the same cystine pattern but the penetrating disulfide bridge is different, i.e. cystine 
knot is knotted in different ways. Lower panel shows schematic representation of the 
structural fold observed for these two families. This scheme is adapted from the 
knottin`s website (http://knottin.cbs.cnrs.fr). 
 
 
Along with the diverse natural biological activity knottins are currently 
considered to be a very promising scaffold for drug design due to their stability, small 
size and high sequence tolerance. 
 
 
 
 
Knottins Growth Factor cystine knots 
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Cystine stabilized a-helix structural motif. 
 
Although cystine knots framework is very abundant among the cysteine rich proteins 
this is not the only possibility of the disulfide bonds arrangement. Distinct structural 
motif among the large variety of the multiple cystine-containing peptides was 
identified in 1991 by Kobayashi et. al. and named “cystine stabilized a-helix” (24). It 
consists of one pair of half-cystines in positions i, i+4, i.e. separated by an intervening 
tripeptide of no sequence homology, disulfide-linked to a second pair of half-cystines 
in positions j, j+2 of a second strand. Many peptides of different origins and functions 
are found to adopt this structural motif. All of them have a consensus cysteine 
framework that can be symbolized as Cys-X1-Cys/ Cys-X3-Cys. In this consensus 
representation “slash” represents any sequence in between the cysteines that may 
even contain additional disulfides. The proteins exhibiting CSH structural motif have 
been reviewed later in 1998 by Tamaoki et. al. (25) and revealed a large variety of 
families such as endothelins (26, 27), sarafotoxins (28), bee and scorpion venom 
toxins (24, 29). Representative 3D structures of the CSH folding motif are shown on 
the figure 11. 
 
 
 
 
Schematic drawing of the consensus structural motif is also adapted from the review 
article by Tamaoki et. al. (25) and shown on figure 9 below. 
Figure 11. 
Backbone structures of ET-1, 
apamin, MCD peptide, CsE v3 and 
ChTX with the portion of the CSH 
motif depicted in magenta and 
disulfide bridges in yellow. The figure 
is adapted from the review article by 
Tamaoki at. al.  
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Furthermore authors of the review made an attempt to extend classification of 
the cysteine patterns and considered the framework of Cys-Xm-Cys/ Cys-Xn-Cys 
where m/n can adopt numbers from 0 to 5. They found that CSH folding motif is 
predominantly found only in case of m/n = 1/3 as it was considered above. 
Nevertheless for the m/n = 3/3 they found several examples of the disulfide bonded 
connections of the anti-parallel a-helices (30) or anti-parallel ß-strands (tachyplesin) 
(31). From the other hand several members of the previously described growth 
factors family satisfy the consensus framework of the CSH fold with two additional 
cysteines in the “slash” sequence. Tamaoki et. al. ascribe such proteins as a distinct 
portion inside the folding motif family with the a-helix replaced by ß-strand.  
The reviewed structures represent only small part of the currently known 
cysteine-rich peptides and stable domains. The large variety of different cysteine-rich 
structural motifs left out of the scope of this introduction because these structures can 
hardly be classified. 
Figure 12. 
Schematic drawing of the CSH 
motif with ball-and-stick models of 
two disulfide bonds. An a-helix 
spanning the Cys-(X)3-Cys 
sequence portion is crosslinked by 
two disulfides to the sequence 
portion Cys-X-Cys, folded into an 
extended b-type structure. 
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Chapter 1* 
 
 
 
 
Self-assembly of NOWA. 
Calcium dependent aggregation of assembled NOWA globules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
* This work was performed in collaboration with Suat Oezbek. 
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Introduction 
The nematocyst capsule wall is composed of the globular building units that 
we termed “capsulomers” (Fig. 6 B of General Introduction) (1). It was shown 
recently that capsulomers consist of both NOWA and mini-collagens (1). In the 
referred article authors showed as well that in the capsulomers of the wall 
polymer NOWA and minicollagens form disulfide-linked hetero-oligomers. This 
was demonstrated by treatment of the nematocysts with mild sonication 
preserving native complexes and subsequent size exclusion chromatography 
followed by biochemical and microscopy studies of the separated capsulomers. 
The high molecular weight peak corresponded to the capsulomers was collected 
and analyzed with the negative staining transmission electron microscopy (TEM). 
The same sample was analyzed by Western blotting under reducing conditions 
with the antibodies against mini-collagen1 and anti-NOWA-CTLD and showed the 
presence of both proteins. Visualization of the isolated capsulomer peak via 
electron microscopy revealed the presence of capsulomers with rather 
heterogeneous distribution. The observed heterogeneity of isolated capsulomers 
was due to the naturally occurring capsulomer size distribution and additionally 
due to the aggregation on the column. 
It has been shown in several publications that the capsule architecture is 
highly sensitive to reducing agents and that Hydra minicollagens are only 
solubilized by reduction (2); (3), (4, 5). It was also demonstrated that 
polymerization of recombinantly expressed minicollagen-1 can be triggered in 
vitro by oxidative reshuffling of the initially soluble collagen trimers (6). As 
cysteine residues are constricted to the short terminal domains of the 
minicollagen molecules a model may be proposed in which the cysteine-rich 
domains function as linkers of a collagen polymer by an intermolecular exchange 
of disulfide linkage. NOWA contains homologous cysteine-rich domains as a C-
terminal octad repeat suggesting a similar assembly process and a possibility to 
link to minicollagens. 
As discussed in the general introduction conglomerates found inside the 
capsule body during early stages of nematocyst morphodenesis are composed of 
globular structures and contain NOWA only. This fact suggests the possibility of 
capsulomer-like globules formation out of isolated NOWA molecules with no mini-
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collagens involved. Sinve mature capsulomers assemble via formation of 
intermolecular disulfide bonds between NOWA and minicollagen molecules 
assembly of capsulomer precursors may be also achieved by disulfide 
isomerization. 
In order to elucidate whether NOWA alone assembles to capsulomer – like 
structures I expressed the full-length protein in mammalian cells and followed its 
assembly by various techniques. In addition similar experiments were performed 
with the recombinantly expressed fragment containing the 8 Cys-rich domains. 
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Materials and Methods 
 
cDNA constructs, expression and purification of recombinant proteins.  
Sequences for full length NOWA and its C-terminal cysteine-rich domain 
comprising residues 464-749 were amplified by PCR using the NOWA 
pBluescript vector as a template. NheI and BamHI sites were introduced in the 5'- 
and 3'- primers, respectively, to enable convenient cloning into the corresponding 
sites of the mammalian expression vector pCEP-Pu. Primers used were:  
5'-TGC GGC TAG CCA GAT CCT CAA CAG TAT GGT TGT TTT TAG CG-3', 5'-
CGG GAT CCT TAG GCT TTA CTT TGC TTT TTT CTT ACG GGA GG-3' for the 
full length NOWA.  
5'-TGC GGC TAG CCC AAA TTA CTG GAA CAT GTC C-3' and  
5'-TTT GGA TCC TTA CAT TCG TCC AAG ACT AC-3'  
for the cysteine-rich domain. For stable transfection, 293 EBNA cells were kept in 
Dulbecco`s modified Eagle’s medium F12 supplemented with 10% fetal bovine 
serum, 1% Gln, and PenStrep. Cells were grown to 80% confluence in 6-well 
plates and transfected overnight with 1 mg of vector DNA using 5 ml of 
Lipofectamine reagent. The selection of positive clones was performed by 
culturing transfected cells with 2 mg/ml puromycin with frequent changes of 
medium until a resistant population appeared. All reagents were purchased from 
Invitrogen. For expression, stably transfected EBNA 293 cells were grown to high 
density in 125-ml cell culture flasks using complete medium and then switched to 
serum-free expression medium. Cell supernatants were harvested several times 
until the cells detached, pooled and filtered. Filtered expression medium was 
dialyzed against binding buffer (20 mM Tris; 300 mM NaCl; 5mM Imidazol) before 
loading on the column. Recombinant proteins were then purified in native 
conditions using nickel-Sepharose chromatography according to the 
manufacturer’s instructions (QIAGEN). Eluted fractions were analyzed by SDS-
PAGE and dialyzed against 50 mM Tris-HCl, pH 8.0, and 150 mM NaCl. 
 
SDS-PAGE, Silver stain and Western blot analysis.  
Samples were incubated in Laemmli buffer with or without ß-mercaptoethanol or 
DTT and separated on 12% SDS-gels. For resolving higher aggregates gradient 
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gels (3-10%) were applied with 2.5% stacker gels. Samples were always 
duplicated for subsequent Silver staining and Western blotting. The following 
protocol for Silver staining was used: 
1.  Fixation - Soak gel for 30 min in 50ml MeOH + 10ml Acetic Acid + 40ml 
MQ-H2O 
2.  Briefly rinse in MQ-H2O; 
3.  Reduce  for 30 min in 30% Ethonol, 100mM Na Acetate pH 6; 
4.  Rinse in MQ-H2O 3 times for 10 min. 
5.  Staining for 30 min in 0.1 % of Silver Nitrate; 
6. Briefly rinse in H2O; 
7. Developer solution : 2.5% Na2CO3.  
 Western blot analysis was performed using mouse antibody directed against His-
tag and polyclonal rabbit antibody raised against Cys-rich octad repeat domain of 
NOWA. Primary antibody (1:1000) was detected using an anti-rabbit-horseradish 
peroxidase conjugate antibody (1:2000) and the ECL chemoluminiscence system 
(Amersham Biosciences). 
 
Antibody production. 
Polyclonal antibody directed against the recombinantly expressed eight folded 
cysteine rich domain of NOWA was generated in rabbits by Eurogentec (Herstal, 
Belgium). Immunization was carried out following a standard protocol using 100 
µg of purified protein in PBS.  
 
Transmission electron microscopy. 
The negative staining of purified NOWA was performed as described elsewhere 
(7). The 300 mesh electron microscopy grids coated with carbon were glow 
discharged. Protein sample was allowed to adsorb on the grid surface for 1-2 
minutes, than blotted, washed by distilled water, blotted again, and stained either 
by 2% Uranil Acetate or 2% Phosphotungstic acid adjusted to pH 7 by sodium 
hydroxide. After staining for 2 minutes samples were washed by water again 
blotted and allowed to air dry completely before insertion into the microscope.  
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 Results and Discussion. 
 
Disulfide-dependent self-assembly of NOWA leads to the formation of 
capsulomer – like structures. 
The proposed self-assembly of NOWA was analyzed by recombinant 
expression of the full-length protein and the isolated cysteine-rich octad repeat 
domain in 293 cells. Both recombinant constructs were designed with N-terminal 
polyhistidine-tag for purification via Nickel-Sepharose chromatography (Fig. 1). I 
introduce the name NCRD for single cysteine-rich domain in NOWA and octad 
NCRD (ONCRD) for the repeat with 8 cysteine rich domains.  
Full-length NOWA was expressed in mammalian cells and purified via Nickel 
chromatography under native conditions. In order to examine the oligomerization 
state of recombinantly expressed protein purified NOWA was analyzed on the 
SDS page by Silver staining under reducing and non-reducing and reducing 
conditions. As it is shown on figure 2A non-reduced material did not enter the 
12% SDS page suggesting the high degree of oligomerization. The same sample 
at the reducing conditions showed single band corresponded to the NOWA 
monomer size. To verify that absence of protein band under non-reducing 
conditions is due to the oligomerization gradient SDS page followed by Western 
blotting was performed. This experiment revealed a protein band recognized by 
NOWA specific antibody of about 1 MDa (Fig. 2B). Treated with mild reduction (1 
mM of DTT) oligomerized protein turned into the ladder of bands corresponding to 
monomers (of 93 kDa apparent size), dimers and higher oligomers of NOWA (Fig. 
2B). These biochemical data show the presence of disulfide bonded oligomers of 
NOWA immediately after purification.  
To examine whether observed oligomerization is a result of the self-
assembly process the experiments described below were performed. 
Although the oligomerization was always observed purified batches of 
NOWA varied in extend of assembly to high oligomers so that rarely a small 
fraction of the material was found to be in monomeric state under non-reducing 
conditions. A monomer-rich sample was analyzed with size exclusion 
chromatography. This experiment revealed two distinct peaks assigned to 
monomeric and highly oligomerized NOWA (Fig 3A). Fractions of both peaks 
 
 
MRSSTVWLFLALLSVALSTEVKDLDAVDEQSTKRDVPTVAVGVPPTLDDEGKLTN 
VTMKKLLSETNRYRLMHGVTPLGSCPVCSEAAQKHADEIAASGVAKPDHNSKYGQ 
IIFSSKDPEDINQGADYFGTLVPARIYNQIKNFDFVKDAFKENAADFSQLVWEGS 
EVVGFASKKAGDTVYVVMYFNPAGNNESLSFYDNVHRVTGSGDMQQKIK 
CPDGWKANNGNCYKLFEEEMAWADAVDHCNVLKSSLFSGESVEEGAFLKTMLVGR 
SSPSWIGMSDMAAKGGFQFVDGTPYVYSDWSRESQQLVIDLWNTKKETVKNQCIT 
ASYEGWNYKDCFKKLPFVCK 
MRPNGMTSYSLDLYFPGSSFTDDLYDINSQRYATMKGVITKAFNESYGKDIWFVG 
STFYQFMSRENGDVAASTLLRFAPDVRAPVDPITKLRDYLRGQTDLKILSVRLIPGSGRGLLPN 
 
QITGTCPSG   CSGDCYPECKPGCCGQVNLNAPVQP 
SGYTACSQYPN CGLSCQSSCSQSCCQQNPYQPSVMSGTIVIQP 
NEQSVCPQHPG CSQHCAPRCSPQCCQQSMNSLYQP 
PQMSACPQFPS CSPTCAPQCSQLCCQQSSMPLQM 
PQMPSCPQFPS CSASCAPQCSQQCCQQPSMSIQP 
LQISSCPQFPS CSPSCAPQCSQQCCQQPSMPIQL 
PLMGSCSQMPG CSASCAPLCSQQCCQQQSMLQQSIMQQPMM 
MAQNPCSLQQPGCSSACAPACRLSCCSLGRMNLGRKRSHVHHKKLKASRKKKQSKA 
NOWA 
ONCRD 
Figure 1.  
The sequence of full length NOWA. Domains organization of recombinantly 
expressed NOWA and ONCRD – eight folded cysteine rich domain of NOWA. Full 
length NOWA has two ONCRD and two sdditional domains: SCP (green) and 
CTLD (aquamarine) Red squares 1-8 are eight times repeated cysteine rich 
domain alltogether called ONCRD. Green and blue colors of the amino acid 
sequence correspond to the domain colors in the schematic representation. In the 
ONCRD part of the sequence aligned cysteines colored in red. Both constructs 
have 6-His-tag for purification purposes. 
 Figure 2. 
Expression and purification of full-length NOWA. 
A, Silver staining of the purified NOWA under non-reducing and reducing 
conditions; Reduced band corresponds to the expected monomer size. Non-
reduced material did not enter the gel. 
B, Gradient SDS page followed by Western blotting analysis of the full length 
NOWA under nonreducing and mild reducing conditions.  
 Figure 3. 
A, Size exclusion chromatography of recombinantly expressed NOWA. Two peaks 
are found and subsequently analyzed by 12 % SDS page Silver staining (B) and 
negatively staining transmission electron microscopy (C, D). C, Insert is a magnified 
view of NOWA capsulomer – like structures. D, Arrows are pointing on the ring-like 
molecules. Bars are indicated on pictures.  
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were collected and analyzed by Silver staining on the SDS page under non-
reducing conditions (Fig. 3B). Expected monomeric band was observed for lower 
mass peak. High molecular weight NOWA oligomers did not enter 12% SDS gel. 
Both samples were analyzed with negative staining transmission electron 
microscopy (Fig 3 C and D).  
The oligomers of NOWA protein appeared as globular particles with a size 
distribution of 17 to 25 nm in diameter. The average diameter of these particles 
was estimated to be 20 nm that is very similar to the diameter of naturally 
occurring capsulomers (Fig 3C) (1). Therefore electron microscopy analysis 
clearly shows that oligomerized form of NOWA has defined shape and thus is 
most probably a result of the ordered self-association process. 
Electron micrograph of NOWA monomers revealed particles of 6-7 nm 
diameters with a tendency of lateral association. Sometimes ring-like structures 
were indicated (Fig 3D). In general, assuming the partial specific volume of the 
protein v = 0.73cm3/g, one can calculate the volume occupied by a protein of 
mass M as follows: 
 
 
 
Assuming that protein is a single globular domain, the radius, Rmin,of the smallest 
spherical particle that could contain a protein of a given mass can be estimated. 
Using the following equation we can calculate the minimum radius for a spherical 
equivalent of the 90 kDa monomeric NOWA protein. 
 
 
 
 
Consequently the minimum diameter of such molecule is 5.9 nm. This matches 
the electron microscopically observed size of the NOWA monomer (6-7 nm) 
suggesting a very compact globular fold of the molecule. Nevertheless limitations 
of the applied method have to be considered. For example, the negative staining 
procedure can lead to some decrease in the observed radius meaning that size of 
the molecules observed with this method can be underestimated. In order to 
 
V = v * NA * M = 108 nm3 for 90 kDa NOWA monomer 
 
 
Rmin = (3 V / 4 p )1/3 = 2.95 nm  
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estimate the upper limit of the monomer diameter we performed rotary shadowing 
transmission electron microscopy of NOWA monomeric fraction. These images 
are presented on the figure 4B (upper panel) and show roughly 9-10 nm. Rotary 
shadowed pictures have to be normally corrected for the decoration with metal by 
subtraction of 2.5 nm. Accordingly an average diameter of monomers revealed by 
rotary shadowing is about 7.5 nm which is almost identical to that observed with 
negative staining. Consequently NOWA monomer is in fact very compact globular 
structure.  
Relaying on the same logic as was used for the monomer radius 
calculations we can estimate maximum number of monomers composing single 
capsulomer-like structure. Assuming spherical shape of NOWA oligomers its 
volume (V = 4/3 p r3) calculated for average 20 nm spheres equals 4187 nm3. On 
the other hand the volume of hypothetical spherical monomer of 2.95nm radius 
was calculated to be 108 nm3. This is minimal possible volume consequently the 
maximum number of monomers composing single average capsulomer will be:  
N = V of oligomeric sphere / V of monomeric sphere = 38 
In reality this number should decrease due to less compact state of the 
particle. Accordingly the biggest NOWA oligomer (25 nm in diameter) can consist 
of maximum 72 monomers and the smallest one (17 nm) can be hypothetically 
composed of 23 monomeric units. The distribution in the number of monomers 
composing single capsulomer-like structure (23 - 72) makes impossible 
estimation of the average molecular mass by ultracentrifugation.  
To assess whether capsulomer-like structures composed of recombinant 
NOWA and compact globular structural fold of monomeric NOWA are disulfide 
dependent features direct electron microscopy visualization of the native and 
reduced states of the monomeric and oligomeric protein fractions was applied 
(Fig. 4). Compact spherical structure of single capsulomer-like globule at the 
native conditions (Fig. 4A left) abolished completely upon addition of the reducing 
agent (1mM DTT) (Fig. 4A right). Reduced sample revealed randomly aggregated 
molecules.  
Figure 4 B shows rotary shadowing of the selected NOWA monomers at the 
native conditions (upper panel) in comparison with the reduced monomers (lower 
panel). Round shaped molecules unwrapped at the reducing conditions and 
 Figure 4. 
A, Negative staining transmission electron microscopy images of folded capsulomer-
like globule made of recombinantly expressed full length NOWA. Samples were kept at 
the following conditions before adsorption on the EM grid: 20mM Tris 50 mM NaCl pH 
7.5 (left image); 20mM Tris 50 mM NaCl 1mM DTT (right image). On the right panel 
disordered aggregates are observed after reduction. 
B, Rotary shadowing transmission electron microscopy analysis of NOWA monomers 
in the native form (upper panel) and those upon reduction with 1mM DTT. 
 39
exhibit the length approximately equal to their circumference. Thus folding of 
NOWA monomers and further self-assembly of monomers into the capsulomer-
like globules are disulfide dependent processes. Presumably cysteine rich 
domain of the protein (ONCRD) is particularly responsible for this.  
In order to investigate whether cysteine rich domain of NOWA exhibits 
behaviour similar to that of the full length protein the ONCRD construct was 
expressed in mammalian cells. After expression and purification ONCRD was 
analysed with the same set of experiments applied to the full length NOWA. Silver 
staining analysis of purified product revealed a single band of 45 kDa protein 
(calculated mass 35 kDa) under reducing conditions (Fig. 5A). The apparent 
mass was higher than expected but mass spectrometry revealed 35.5 kDa mass. 
Unlike the full-length NOWA the ONCRD under non-reducing conditions did not 
show high oligomeric band on the gradient (3% - 10 %) gel although reduction led 
to the monomer appearance (Fig 5B). Monomeric fraction was sometimes (but 
very rarely) observed on the non-reduced SDS page. However Isolation of 
ONCRD monomers by size exclusion chromatography failed because of the low 
extinction coefficient accompanied by little amount of the material. Thus instead 
of separate analysis of monomeric and oligomeric fractions crude purified 
ONCRD was subjected for electron microscopy negative staining. Results 
represented on figure 5 C and D. ONCRD oligomers appeared as globular 
particles of 10 – 13 nm in diameter which are often connected to each other. 
Close view of the ONCRD globules showed pronounced ring appearance (Fig. 
5D). These rings are presumably composed of ONCRD monomers that are 
disulfide interlinked and sometimes seem to undergo further cyclization process 
(Fig 5C). Summarizing observed features of the ONCRD in comparison with full 
length NOWA behaviour one can speculate that cysteine rich domain induces 
self-assembly by a cyclization process. This process is unlimited and rather 2-
dimensional in case of ONCRD when in case of the full-length NOWA assembly 
is controlled and able to proceed in all directions. Probably other domains of 
NOWA contribute to self-assembly by providing non-covalent interactions and on 
the other hand by restriction of assembly process to a certain extent as the octad 
repeat domain alone appears to form larger polymers.  
 
 
 
 Figure 5. 
A, Silver staining analysis of the recombinant purified ONCRD under 
reducing conditions. B, Western blotting of the same sample reduced 
and non-reduced. C, Electron microscopy negative staining micrograph 
of the purified ONCRD. Red arrow indicate close view of the round 
particle (D). Aquamarine arrow shows cyclization of the round particles. 
Round structures are in fact rings as seen from the higher magnification 
picture (D). 
 40
Thus self-assembly of NOWA is spontaneously happening in vitro with the 
recombinant product. It is a disulfide-dependent process that is predominantly a 
feature of NOWA cysteine-rich domain. The recombinant ONCRD forms ring 
structures instead of NOWA capsulomer-like globules. 
 
Calcium dependent aggregation of NOWA capsulomer-like globules. 
On the figure 6 A and B we represent the data extracted from the fixed angle 
rotary shadowing and neutral staining transmission electron microscopy analysis 
of recombinant NOWA at the 5 mM Ca2+ concentration. Globular capsulomer-like 
particles discussed above are obviously associated into the clusters. These 
clusters are of different size and shape. Represented TEM images allow to 
distinguish single capsulomers as building units of bulky conglomerates. 
Shadows indicate the height of the individual globules as well as the whole 
clusters on the Fig. 6A. This association is a calcium dependent process. Figure 
6C visualizes the same batch of recombinantly expressed NOWA as on figure 6A 
but in the absence of divalent ions (5mM of EDTA was added after purification 
and dialysis against 20 mM Tris buffer). Clearly there are no aggregates higher 
than capsulomers exist under these conditions.  
Calcium dependent aggregation of NOWA capsulomers is an important 
observation in terms of nematocyst morphogenesis. It was described in the part 1 
of General Introduction that clusters composed of NOWA were found in the body 
of developing nematocyst. At the certain time of capsule morphogenesis these 
clusters dissociate towards the capsule wall. Comparison of the in vivo findings 
with the observed calcium dependent aggregation of recombinant NOWA 
proposes that in vivo “melting” of the NOWA clusters is as well calcium 
dependent process.  
Calcium dependent cluster formation does not happen to the rings formed 
by recombinant cysteine rich domain of NOWA. As evident from the EM study the 
degree of ONCRD polymerization is not dependent on the presence of calcium 
(data not shown). Consequently, one of the two other domains of NOWA must be 
responsible for calcium aggregation. We assign this property to the C-type lectin 
domain of protein. This domain is known to bind carbohydrates and other ligands 
in calcium dependent manner in many proteins (8). It is also found to have very 
 Figure 6. 
Transmission electron microscopy analysis with fixed angle rotary 
shadowing technique (A) and neutral staining (B) of recombinantly 
expressed full length NOWA at different content of CaCl2. Figures A and 
B represent conditions at 5 mM calcium. C – 5 mM EDTA (no divalent 
ions present in the protein solution). 
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high tendency to dimerize. Taking these facts into account one can think of 
similar mechanisms of NOWA capsulomers aggregation i.e. exposed CTLDs can 
potentially either undergo dimerization with the same domain of different 
capsulomer precursor or bind its glyco- residues. As was mentioned earlier 
NOWA is a glycosilated protein. In both scenarios binding mechanism would be 
calcium dependent process. Alignment of NOWA C-type lectin domain against 
other members of the super family gives reasonable similarity. Circular dichroism 
spectra of this domain showing the presence of both helices and betta-sheets in 
the secondary structure, though exhibiting no change with calcium content 
variation. All known CTLDs are shown to have very similar structure fold including 
two alfa-helices and several ß – strands independently of their degree of 
sequence similarity (8). The only significant difference among all these domains is 
presence or absence of the loop, which is usually but not necessarily responsible 
for the calcium binding. We have no structural evidence for the presence of such 
loop in NOWA C-type lectin domain but still this domain is the most prominent 
one in terms of calcium dependent aggregation of NOWA. 
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Abstract 
 
Nematocyst capsule wall formation is happening inside the Golgi vesicle. 
Membrane serves as a substrate for the developing capsule at the early 
stages of nematocyst morphogenesis. Moreover as shown by transmission 
electron microscopy (1), the nematocyst is completely enclosed by a vesicular 
membrane in the mature form. We discussed in the general introduction that 
NOWA found in two states during capsule morphogenesis one of which is 
located inside the capsule body in a clusters form and the other is colocalized 
with the membrane of Golgi vesicle. The membrane associated form of 
NOWA protein is already identified at the very early stages of capsule 
formation. Consequently it has been proposed that NOWA is able to interact 
with the Golgi vesicle membrane. The mechanism of such interaction is an 
interesting feature in terms of understanding of the nematocyst capsule wall 
assembly and structure. In order to demonstrate and investigate NOWA - 
membrane interaction in vitro we have applied several independent qualitative 
and quantitative approaches. By these methods the ability of NOWA to 
interact with the model negatively charged (75% POPC : 25% POPG) 
phospholipid bilayer as well as with monolayer of the same composition was 
demonstrated. Binding of NOWA to the model membrane composed of 100% 
POPC was found to be negligible. Kinetic surface plasmon resonance studies 
allowed us to determine the binding constants in the presence and absence of 
calcium. In order to map a protein sequence responsible for the membrane 
association we investigated separate NOWA domains interaction with the 
model membranes. Two likely candidates were identified: C-type lectin 
domain and basic terminal sequence of the protein. 
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Introduction. 
Nematocyst outer wall antigen (NOWA) was identified initially as a protein 
composing the outer wall of the nematocyst capsule wall. Further studies 
revealed rather homogeneous structure of the wall and presence of NOWA 
along with minicollagen in the wall structural building units “capsulomers”. 
However during the morphogenesis of the nematocyst capsule NOWA was 
found in two distinct forms: a cluster form accumulated inside the developing 
capsule body and a form associated with the membrane of the Golgi vesicle 
already at the very early stages of the capsule development. Later on cluster 
form of the protein has melted and dissociated toward the wall of the future 
nematocyst (2). This phenomenon was discussed to be a feature of the 
calcium dependent aggregation of NOWA (see chapter 1). At all time of the 
nematocyst development Golgi membrane serves as a substrate for the 
capsule wall formation (3). A mature nematocyst is found to be completely 
enclosed by a vesicular membrane as it is evident from the electron 
microscopy study (figure 
below adapted from Golz, 
1994) (1). In its 
basolateral portion, this 
membrane is separated 
from the cell membrane 
by a more than 0.5 µm 
thick cytoplasmic layer 
containing other 
intracellular membranes 
and a complex 
cytoskeleton. At its apical 
part, however, the nematocyst membrane is closely apposed to the cell 
membrane of the opercular region, forming a putative contact region of up to 1 
µm2. Here are vesicular and cell membranes separated by a thin cytoplasmic 
lamella of less than 50 nm. Therefore the nematocyst wall is always in a close 
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contact with vesicular membrane suggesting an interaction of the wall proteins 
with this membrane.  
In the present study we investigated the binding of the recombinantly 
expressed and self-assembled NOWA to the model phospholipid monolayers 
and bilayers. We found out that such binding does exist and membrane bound 
protein was shown to be in the capsulomer-like associated form. The 
mechanism of NOWA – membrane interaction was a second subject that we 
tried to approach in this chapter. To recognize the particular domain of the 90 
kDa protein which is responsible for membrane affinity we investigated two 
recombinantly expressed NOWA domains: CTLD and ONCRD. The very C-
terminal sequence of NOWA is enriched by positively charged Lys residues 
and is expected to be flexible. Regions with clusters of lysines are often found 
to be membrane associated or even penetrate the membranes. For instance 
so called cell penetrating peptides such as Tat of Penetratin contain 
preferentially arginines and lysines in their sequences (4). These peptides use 
electrostatic attraction to bind and consequently penetrate negatively charged 
membrane surfaces. We suggest that similar mechanism can be utilized by 
NOWA. In addition the data clearly indicated that CTLD (C-type lectin domain) 
of the protein plays a role in the membrane binding as well.  
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Materials and Methods. 
Transmission electron microscopy. 
The negative staining of purified NOWA was performed as described 
elsewhere. The 300 mesh electron microscopy grids coated with carbon were 
glow discharged to make the surface hydrophilic. Protein sample was allowed 
to adsorb on the grid surface for 1-2 minutes, than blotted, washed by distilled 
water, blotted, and stained either by 2% uranil acetate or 2% phosphotungstic 
acid adjusted to pH 7 by sodium hydroxide. After staining for 2 minutes 
samples were washed by water again blotted and allowed to air dry 
completely before insertion into the microscope. Samples for protein - lipid 
monolayer interaction studies were prepared as illustrated on figure 1. 
 
 
 
Figure 1. Experimental set-up for deposition of phospholipid monolayer 
together with bound NOWA on the surface of hydrophobic carbon film (not 
glow discharged) of EM grid. 
 
 Briefly, 20 l of the protein solution in 10mM Tris 50mM NaCl buffer was 
placed in a Teflon trough (3 mm diameter, 0.5 mm deep). The surface of the 
solution was coated either with 1 l of the egg L-a-Phosphatydilcholine (PC) 
or lipid mixture of 75% PC and 25% of L-a-Phosphatidylglycerol (PG) at a final 
concentration of 0.5 mM in chloroform/hexane 1:1 (v/v). After evaporation of 
organic solvent the lipid monolayer is formed at the air/water interface. The 
trough was incubated for 30 minutes at room temperature in a closed humid 
chamber. The concentration of proteins (NOWA and 8 repeated MCRDC) was 
50 g/ml. A 300 mesh carbon coated electron microscopy grid was placed on 
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top of the lipid monolayer, which was allowed to adsorb spontaneously on the 
hydrophobic surface of carbon film. Neutral negative staining of the 
monolayer-bound protein was performed and samples were analysed with 
transmission electron microscope. Schematic representation of described 
procedure shown on the figure 1. Electron microscopy of liposomes was 
performed using the same staining protocol (neutral negative stain). In all 
cases when samples contained lipids EM grids were not glow discharged to 
keep the surface of carbon grid hydrophobic and to avoid 
hydrophilic/hydrophobic mosaic. All phospholipids were purchased from 
Avanti Lipids, Inc. 
Chemical formula of L-alfa-Phosphatydilcholine (PC): 
 
For the L-alfa-Phosphatidylglycerol (PG): 
 
 
Liposomes preparation. 
SUV liposomes.  
SUV (small unilamelar vesicles) were used for the immunofluorescent staining 
experiments as well as for the SPR (surface plasmon resonance) kinetic 
measurements (Biacore). Two types of liposome compositions were used: 
neutral 100% phosphatidylcholine (PC) and negatively charged 75% PC + 
25% PG mixture. For preparation of SUVs lipids were dissolved and mixed (in 
case of PC/PG mixtures) in an organic solvent (chloroform : methanol mixture) 
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at the concentration of 50 mg lipid/ml organic solvent to assure a 
homogeneous mixture of lipids. Once the lipids are thoroughly mixed in the 
organic solvent, the solvent was evaporated using a dry nitrogen stream to 
yield a lipid film. The lipid film was thoroughly dried to remove residual organic 
solvent by placing the vial on a vacuum pump overnight. Hydration of the dry 
lipid film was accomplished simply by adding buffer (identical to the one used 
for protein solution) to the container of dry lipid and agitating. Typically the 
concentration of lipids in the hydration medium was 5mg/ml. The temperature 
of the hydrating medium was heated above the gel-liquid crystal transition 
temperature (Tc or Tm) of the lipid with the highest Tc before adding to the dry 
lipid. After addition of the hydrating medium, the lipid suspension was always 
maintained above the Tc during the hydration period. Hydration time was 
above 1 hour with vigorous shaking, mixing, or stirring. Once a stable, 
hydrated LMV (large multilamellar vesicles) suspension has been produced, 
the particles was downsized by sonication. Disruption of LMV suspensions 
using sonic energy (sonication) produced small, unilamellar vesicles (SUV) 
with diameters in the range of 15-50nm. Probe tip sonicator was used with 
high energies but careful temperature control (to avoid overheating). The 
sonication tip releases titanium particles into the lipid suspension which have 
been removed by centrifugation prior to use. Upon sonication the lipid 
suspension yielded a slightly hazy transparent solution. The haze is due to 
light scattering induced by residual large particles remaining in the 
suspension. These particles were removed by centrifugation to yield a clear 
suspension of SUV. The small unilamellar liposomes suspension was used for 
bilayer formation on surface of the Biacore chip L1 (5) or on the quartz slide 
soaked in Poliethyleneimine (PEI) (6). 
 
Preparation of giant liposomes. 
Gentle hydration method 
Stock solutions of phospholipids (100% PC or 75% PC / 25% PG mixture) 
were made in chloroform. Lipid films were prepared as described above for 
SUV. The dry lipid mixtures were hydrated gently without agitation in pure 
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Millipore water (17.5 MW/cm) at 37°C (this temperature is above both 
phospholipid transition temperatures). A characteristic cloud containing giant 
liposomes was observed after several hours of incubation (12 to 36 hours) as 
previously described (7). Giant liposomes were examined under the light 
microscope. Typically  size distribution of 0.3 - 3 µm was detected.  
 
NOWA interaction with giant liposomes. 
In order to study NOWA interaction with giant liposomes we used the following 
experimental procedure. Giant liposome solution of the desired lipid 
composition has been mixed with the recombinantly expressed and purified 
protein and incubated for several hours. For separation of the liposomes with 
the bound NOWA from unbound protein the solution mixture was centrifuge at 
275000 g in a sucrose gradient. The visible liposome containing fraction was 
collected and used for transmission electron microscopy.  
NOWA – bilayer interaction studied by fluorescent immunostaining. 
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Figure 2. Conceptual diagram of polymer-cushioned bilayer at the solid-
solution interface. In our case the solid substrate was optically polished 
monocrystalline quartz slide. The arrows indicate polymer substrate for the 
model membrane deposition, model membrane and direction of liquid flow 
during injections. 
 
Special flow chamber demonstrated on figure 2 has been designed to perform 
immunofluorescent study of the NOWA - lipid bilayer interaction. For this study 
we used polymer cushioned phospholipid bilayer as a model membrane. The 
Polyethyleneimine PEI was used as a substrate for the PC/PG bilayer (6). The 
quartz slide was immersed in a 100ppm PEI solution of 0.5mM KNO3/H2O 
(Milli-Q water, pH ~7) for 15 minutes and allowed to dry for several hours. In 
the second step, the PEI-coated quartz was transferred into the flow cell filled 
with H2O, and SUV vesicles of desired composition (100%PC or 
75%PC/25%PG) were added from an aqueous stock suspension (1 mg/ml) to 
a final concentration of 0.14 mg/ml lipids. Bilayer formed spontaneously on the 
polymer substrate. To perform NOWA – membrane interaction study 50µg/ml 
of purified NOWA solution was injected and washed consequently by buffer 
50mM Tris 100mM NaCl. To recognize NOWA bound to the bilayer the anti-
MCRD (NOWA) polyclonal antibody, anti-rabbit secondary antibody labelled 
by FITC have been consequently injected. Each injection followed by washing 
with 50mM Tris 100mM NaCl buffer. The control experiment to ensure the 
absence of non-specific antibody membrane binding was performed. Control 
lacks the protein injection. Samples were examined by confocal microscopy.  
Surface Plasmon Resonance principles. 
To investigate the kinetics of NOWA – membrane, separate NOWA domains – 
membrane and C-terminal MCRD of mini-collagen – membrane interaction we 
applied surface plasmon resonance method utilized by Biacore technology. 
Surface plasmon resonance (SPR) arises when light is reflected under certain 
conditions from a conducting film at the interface between two media of 
different refractive index. In Biacore systems the media are the sample and 
the glass of the sensor chip, and the conducting film is a thin layer of gold on 
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the chip surface. SPR causes a reduction in the intensity of reflected light at a 
specific angle of reflection. This angle varies with the refractive index close to 
the surface on the side opposite from the reflected light (the sample side in 
Biacore). When molecules in the sample bind to the sensor surface, the 
concentration and therefore the refractive index at the surface changes and an 
SPR response is detected. Plotting the response against time during the 
course of an interaction provides a quantitative measure of the progress of the 
interaction. This plot is called a sensorgram. What Biacore actually measures 
is the angle of minimum reflected light intensity. The light is not absorbed by 
the sample: instead the light energy is dissipated through SPR in the gold film. 
Thus the light used to detect interaction processes never enters the sample. 
SPR response values are expressed in resonance units (RU). One RU 
represents a change of 0.0001° in the angle of the intensity minimum. For 
most proteins, this is roughly equivalent to a change in concentration of about 
1 pg/mm2 on the sensor surface. The exact conversion factor between RU 
and surface concentration depends on properties of the sensor surface and 
the nature of the molecule responsible for the concentration change. Figure 3 
illustrates the Biacore technology described above. The figure is adapted from 
the Biacore website. 
 
 
Figure 3. Illustration of the  the Biacore technology principles. This figure is 
adapted from the Biacore website (www.biacore.com). Light passed through 
the prism is totally reflected. There are minimums in the intensity of the 
reflected light observed at the certain angles that are due to the surface 
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plasmon resonance. . This angle is a measure of the sample side media 
refractive index that change depending on mass bound to the ligand. The 
larger the angle the more mass is bound on the surface of the chip. As a result 
one can measure resonance signal time dependence.  
 
Bilayer formation on the surface of L1 chip. 
The surface of Biacore L1 chip consists of dextran modified with lipophilic 
compounds. These lipophilic compounds function the same way as previously 
described polymers for cushioned membranes. They allow the formation of 
lipid bilayer on the surface Formation of such a bilayer was directly monitored 
by the SPR signal (RU) reflecting the amount of lipids on the surface. Figure 5 
shows a characteristic sensogram of egg PC bilayer formation on the surface 
of L1 Biacore chip. from the injected unilamellar vesicles (see figure 4 below). 
SDS-PAGE and Western blot analysis. 
Samples were incubated in Laemmli buffer with or without b-mercaptoethanol 
and separated on 12% SDS-gels. Western blot analysis was performed using 
polyclonal antibody (rabbit) raised against Cys-rich octad repeat domain 
(ONCRD) of NOWA. Primary antibody (1:1000) was detected using an anti-
rabbit-horseradish peroxidase conjugate antibody (1:2000) and the ECL 
chemoluminiscence system (Amersham Biosciences). 
 
 Figure 5.  
Typical sensogramm of PC phospholipids coupling to the Biacore chip L1. RU is a 
resonance units that reflect the mass bound to the surface of biosensor chip. The 
response was typically about 5000 RU. Liposomes capturing was performed at 
the low flow rate 5 µl/min during 900 seconds (15 minutes) following by the buffer 
wash. Signal was stable for at least 24 hours. In order to investigate binding of 
NOWA to the model membrane proteins were injected over immobilized bilayer in 
different concentrations at the flow rate 10 µl/min. 
 
Figure 4.  
Biacore chip L1 designed for 
liposomes capturing thus 
creating a bilayer on the 
substrate of lipophilic residues. 
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Results and Discussion. 
 
NOWA – lipid monolayer interaction. 
Direct visualization of the NOWA binding to the model membrane has been done with 
neutral staining transmission electron microscopy. A technique commonly used for 
the two - dimensional protein crystallization was applied (8). Briefly this technique 
implies protein two - dimensional crystallization on the surface of the lipid monolayer. 
For the His-tagged soluble proteins lipid derivatized with a Ni2+-NTA head group 
molecule in 25% ratio was frequently used (8-11). Proteins at different concentrations 
were incubated with the lipid monolayer spontaneously created on the water/air 
interface. After certain incubation time lipid monolayer carrying bound protein was 
deposited on the non-discharged carbon EM grid, stained and analyzed with 
transmission electron microscopy in order to obtain 2D crystals. This approach 
allowed to observe proteins in certain predominant orientation even if two-
dimensional crystal did not form. In order to study NOWA – monolayer interaction 
exactly the same procedure was applied but instead of Ni2+-NTA lipids either pure 
phosphatidylcholine (PC) or a mixture of 25% negatively charged 
phosphatidylglycerol (PG) and 75% PC were used. Experimental setup is shown on 
Fig. 1 and experimental procedure is described in details in the materials and 
methods section of this chapter. The idea of such setup is that only protein bound to 
the lipid monolayer can be visualized. If interaction did not exist we would observe 
nothing or lipid monolayer. In addition to qualitative control of the protein-membrane 
interaction this approach allows to see the preferential orientation of the bound 
molecules. Figure 6 represents transmission electron microscopy analysis of the 
recombinantly expressed full length NOWA protein bound to the surface of the lipid 
monolayer. Capsulomer-like structures are clearly connected to the negatively 
charged membrane (Fig. 6 A, C). Neutral PC phospholipid monolayer carried no 
bound protein as it is shown on figure 6 B. Figures A and B are presented at the 
same magnification. Figure C is a close view of A where the structure of phospholipid 
monolayer as well as well defined NOWA capsulomer-like globule are unambiguously 
observed. Regions of monolayer covered carbon film can be clearly distinguished 
from the non-covered carbon film. On the figure 6 the boarders of such regions 
 Figure 6 
Transmission electron microscopy analysis of NOWA interaction with 
negatively charged (75% PC+25% PG ) phospholipid monolayer (A, C). In 
contrast to the negatively charged monolayer the neutral 100% PC model 
membrane carrying no bound protein (B). Figures A and B are presented at 
the same low magnification. Figure C is a close view of A where the structure 
of phospholipid monolayer as well as well defined NOWA capsulomer 
precursors are unambiguously observed. Regions of monolayer covered 
carbon film can be clearly distinquished from the non-covered carbon film. The 
boarders separating these regions are indicated by arrows. In comparison to 
the monolayer neutral negative staining of NOWA adsorbed on the surface of 
non-discharged carbon grid is represented on figure D.  
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indicated by arrows. Neutral negative staining of NOWA adsorbed on the surface of 
non-discharged carbon grid is represented on figure D. 
 
NOWA – bilayer interaction. 
Binding of NOWA to the giant liposomes.  
Considering the fact that NOWA is a secreted protein and has no predicted 
transmembrane sequences we assumed that membrane affinity of this protein is due 
to its interaction with the surface of the membrane. Electron microscopy analysis 
qualitatively demonstrated NOWA – monolayer surface affinity is strongly supporting 
the above assumption. In general, transmembrane domain would need some space 
inside the membrane to be incorporated. Therefore lipid monolayer adsorbed on the 
EM carbon grid most likely could not supply enough space for incorporation of 
transmembrane protein. Nevertheless lipid bilayer is a better model of the real 
cellular membrane. Consequently we performed our further investigation of NOWA – 
membrane interaction including kinetic studies using bilayer as a model system. As a 
qualitative control we used transmission electron microscopy analysis of NOWA 
capsulomers binding to the “giant” liposomes. Giant liposomes were prepared by 
gentle hydration method as described in details in materials and methods section. 
Recombinantly expressed and purified NOWA was added into solution of the giant 
liposomes and incubated for several hours. Giant liposome fraction was separatated 
via centrifugation and used for neutral negative staining TEM. On the figure 7 upper 
panel represents resulting liposomes with bound NOWA capsulomers. Lower panel 
of figure 7 shows magnified view of the capsulomer-like globules on the surface of 
liposome or at its border. The locations of magnified regions indicated by circles and 
arrows. Only negatively charged liposomes carried the protein. Liposomes composed 
of pure neutral phosphatidylcholine (PC) had normal shape but capsulomer 
precursors were not found on their surface (data not shown). These data clearly 
demonstrate the affinity of NOWA to the negatively charged phospholipid bilayer.  
 
NOWA – bilayer interaction.  
Immunofluorescent study. 
In addition to electron microscopy analysis of the giant liposomes we performed 
immuno fluorescent staining of NOWA bound to the flat negatively charged bilayer. 
 Figure 7. 
Transmission electron microscopy analysis of NOWA capsulomers binding to the 
“giant” liposomes. Upper panel shows single liposomes stained with 2% Na Ph after 
incubation with recombinantly expressed NOWA and separation of liposome fraction 
from the unbound protein fraction. Lipid composition of liposomes was 75% 
POPC+25% POPG. Lower panel is a close view of the capsulomer precursors on the 
surface of liposome or at its border. Particular locations of the magnified regions are 
indicated by circles and aroows. 
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Special flow chamber has been constructed for this experiment. Figure 2 in the 
materials and methods section of this chapter demonstrates a conceptual diagram of 
polymer-cushioned bilayer at the solid-solution interface that coincides with the 
constructional principles of the designed flow chamber. In our case the solid 
substrate was optically polished monocrystalline quartz slide. Arrows shown on figure 
2 indicate polymer substrate (polyetheleneimine) for the model membrane deposition, 
model membrane and direction of liquid flow during injections. This method of the 
model membrane deposition allows formation of defined lipid bilayer on the surface of 
polymer substrate (6). Injection of NOWA over lipid bilayer followed by injections of 
specific antiboby, washing buffer, fluorescently labelled secondary (anti-rabbit) 
antibody and washing buffer accordingly. Results were observed with confocal 
microscope and are presented on the figure 8. Data from the described set of 
injections shown on figure 8A is compared to the control experiment where injection 
of NOWA has been omitted (Fig. 8B). Control experiment ensures the absence of 
non-specific antibodies - model membrane interaction. Positive experiment (Fig.8A) 
supplies another proof for the NOWA – negatively charged membrane interaction. 
Furthermore observable shape of the membrane bound protein is again spherical 
and some cluster formation of the NOWA capsulomers can be noticed. Summarizing 
qualitative protein-membrane binding experimental data we can now confirm the 
following thesis: 
- recombinantly expressed NOWA binds to the model membrane systems of the 
25% : 75% of negatively charged : neutral phospholipid composition;   
- such binding happens with similar efficiency to the monolayer and bilayer of 
the same composition; 
- neutral membrane systems do not bind the protein. Consequently electrostatic 
mechanism might be important for NOWA – membrane interaction; 
- NOWA–membrane association does not interfere with capsulomer-like 
globules formation. NOWA capsulomers are able to form cluster of the 
membrane surface. 
Nevertheless two questions are still open: how strong is the NOWA-membrane 
interaction and what protein sequence or domain is responsible for this association. 
In order to answer these questions quantitative kinetic study of the NOWA and its 
separate domains interaction with the charged bilayer have been performed.   
 Figure 8 
Immuno-fluorescent study of NOWA - membrane interaction. Figure represents 
confocal microscopy images of the positive NOWA – charged lipid bilayer 
interaction (A) and negative control (B). Experimental setup is described in 
materials and methods and shown on figure 2. Injections were as follows: A, 
NOWA, anti-OMCCR polyclonal antibody, washing buffer, anti-rabbit secondary 
antibody labelled by FITC, washing buffer consequently. Washing buffer 
composition was 50mM Tris 100mM NaCl pH 7. Control experiment was done 
with the same set of injections except injection of NOWA. Bar is 10?m. Figure A 
is a stereo image. 
 
 57 
To investigate the kinetics of NOWA – membrane, separate NOWA domains – 
membrane and C-terminal mini-collagen cysteine rich domain (MCRD) – membrane 
interaction we applied surface plasmon resonance (SPR) method utilized by Biacore 
technology. The use of biosensors employing surface plasmon resonance (SPR) 
provides excellent instrumentation for a label-free, real-time investigation of 
biomolecular interactions. General principles of SPR technology described in the 
materials and methods section can be summarized in a following way. Surface 
plasmon resonance arises when light is reflected under certain conditions from a 
conducting film at the interface between two media of different refractive index. SPR 
causes a reduction in the intensity of the reflected light at a specific angle of 
reflection. This angle varies with the refractive index close to the surface on the side 
opposite from the reflected light i.e. sample side. Sample side refractive index 
changes depending on the mass bound on the surface of the chip. Therefore 
monitoring of the SPR angle directly corresponds to the mass change on the surface 
of biosensor chip. In our case the surface of the biosensor chip represented by the 
surface of model membrane immobilized on the Biacore L1 chip substrate. This 
biosensor chip has modified dextran matrix allowing the capture of the lipid vesicles 
and formation of a flexible phospholipid bilayer. Phospholipid liposomes composed of 
phosphatidylglycerol and phosphatidylcholine were injected onto the surface of a L1 
biosensor chip. Because injection of 50 mM NaOH did not change the mass 
immobilized to the biosensor chip, it was concluded that a stable phospholipid bilayer 
had formed on the chip. Typical sensogram of the bilayer formation is shown on 
figure 5 of materials and methods section. The surface plasmon resonance signal 
from the immobilized bilayer was typically about 5000 RU. This signal was stable for 
at least 24 hours and was not changed upon washing with any of the incubation 
buffers (data not shown). The experiments comprising separate set (related to the 
particular specie at the certain conditions) were performed during the time of bilayer 
stability. To ensure the completeness of the chip coverage by the model membrane 
we used a short pulse of the 0.1 mg/ml serum albumin (BSA). It is known that BSA 
interacts with the L1 biosensor chip modified dextran matrix (about 400 RU) but does 
not interact with the lipid bilayers (20 RU). Response signal from the surface 
assembled model membrane has been corrected to zero for all kinetic curves. Flow 
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rate for all kinetic measurements was 10 µl/min which allowed to avoid diffusion 
limited kinetic and to minimize the usage of protein at the same time.  
In order to demonstrate the presence of NOWA protein on the surface of model 
membrane (25% PG) after injection of protein the experiment shown on figure 9 has 
been performed. At zero time NOWA solution has been injected over previously 
immobilized lipid membrane. Injection was stopped at 150 seconds and immediately 
followed by the injection of the antibody against C-type lectin domain of NOWA. 
Specific antibody – protein interaction unambiguously showed that NOWA was 
present on the lipid bilayer. Non-specific interaction of anti/NOWA/CTLD with the 
model membrane has been checked and found to be negligible compare to the 
protein – antibody recognition. Dissociation of the NOWA – antibody complexes 
started at 300 seconds (Fig.9 indicated by arrow). This dissociation kinetic coincides 
with the dissociation kinetic of NOWA from the membrane as will be demonstrated 
later in this chapter. Therefore described experiment clearly shows the possibility of 
quantitative kinetic analysis of the NOWA binding to the phospholipid bilayer.  
In order to determine KD value for NOWA – membrane association we 
measured concentration dependent kinetics and plotted the equilibrium response 
signal against logarithmic scale of the molar protein concentration. Corresponding 
dissociation constants were determined from the resulting equilibrium isotherm as a 
protein concentration at 50% saturation. NOWA – membrane association was found 
to be calcium dependent. Therefore two sets of concentration dependent kinetics 
were measured in the presence and absence of Ca2+. These data are presented on 
the figure 10. According KD values determined from the equilibrium isotherms are 
specified on the lower panel of figure 10. The isotherm plotted for the set of 
experiments with calcium did not rich the saturation consequently KD value in this 
case could not be determined reliably by this approach. Measurements of the higher 
NOWA concentrations were not possible because of the protein precipitation in the 
solution. As we already seen from the qualitative binding experiments NOWA – 
membrane interaction is a complex process of capsulomer – like structures 
association in parallel with aggregation of protein on the surface and in solution. Thus 
binding constants determined by the equilibrium analysis are can not be considered 
reliable. 
 Figure 9. 
Biacore study of the NOWA – negatively charged (25% PG : 75% PC) lipid 
bilaer interaction. Response signal from the surface assembled model 
membrane has been corrected to zero. Flow rate was 10 µl/min. At zero time 
NOWA in the concentration of 777 nM has been injected over lipid membrane. 
Injection was stopped at 150 seconds and immediately followed by the 
injection of the antibody against C-type lectin domain of NOWA. Dissociation 
of the NOWA – antibody complexes started at 300 seconds. At this time 
injected antibody solution was replaced by running buffer of the same 
composition as it was used for both protein and antibody (10 mM Tris, 50mM 
NaCl pH 7)..  
 Figure 10. 
Analysis of NOWA – lipid bilayer interaction. Association and dissociation kinetics 
of NOWA – model membrane have been measured by surface plasmon 
resonance at different protein concentrations. Composition of running buffers 
were 10 mM Tris, 50mM NaCl (A) and 10 mM Tris, 50mM NaCl, 10mM CaCl2 (B). 
The equilibrium response signal was plotted against logarithmic scale of molar 
protein concentration C, D for both sets of experiments. Corresponding Kd values 
determined as a concentration at the half saturation indicated on figures. 
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In addition to the equilibrium isotherms analysis we applied kinetic analysis to 
determine association, dissociation rates and therefore kineticly derived binding 
constants. Due to the complex binding behaviour kinetic data could not be fitted by a 
simple model implying the binding of single specie to a single binding site, i.e A + B = 
AB for association phase and AB = A + B for dissociation. However a model 
assuming parallel dissociation of two different complexes applied to the dissociation 
phase fitted the curves with reasonable accuracy. This model can be described in the 
following terms: AiBj = Ai + Bj. By fitting the data to this model we have calculated 
the dissociation rate constants kd1 and kd2 for two complexes that are independently 
dissociate from the membrane surface. These two complexes are found to dissociate 
with the rates which differ ten times in the order of magnitude (table 1). In terms of 
our system two independent species as single capsulomer-like globules and 
aggregates of any size higher than single capsulomer. Cluster (aggregates) formation 
was found to be calcium dependent (see chapter 1). Although we performed the 
kinetic measurements in the absence of calcium chelating agents were not added in 
the solution implying the presence of some residual divalent ions. Consequently 
some clusters were present in protein solution as it was always seen by transmission 
electron microscopy. In addition to the existing solution aggregates there is an 
aggregation process happening on the surface of the model membrane. We 
assigned higher dissociation rate to the aggregates of NOWA capsulomers no matter 
of their origin (solution or surface aggregation). Single capsulomer precursors 
appeared to have very slow dissociation rate constant in the other words single 
NOWA capsulomers almost irreversibly bind to the negatively charged membrane 
surface. This was already obvious from the qualitative studies. In all qualitative 
experiments NOWA bound to the membrane was extensively washed out 
nevertheless every time protein stayed on the surface. Although some clusters were 
also present on the surface of lipid monolayer single capsulomer – like structures 
were found to be much more abundant. We assumed in our kinetic study that single 
capsulomer-like globules have higher affinity to the membrane surface and therefore 
higher association rate in addition to the slower dissociation rate. Using above 
assumptions we performed an analysis of the binding kinetics in the presence and 
absence of calcium. The curves were well fitted using Biaevaluation software 
supplied by Biacore. The resulting rate constants and according affinity constants are 
  kd1 (s)
-1    kd2 (s)
-1 ka1 (M*s)
-1 KD1 (M) (I) KD (M) (II) KA1 (M)
-1(I) 
 
NOWA full length 
no CaCl2 
 
(1.6± 0.4)× 10-3 
 
(3 ± 1)× 10-2 
 
(2.3 ± 0.5)× 104 
 
(0.7± 0.3)×10-7 
  
 
(0.8 ± 0.2)×10-6 
 
(1.6 ± 0.9)×107 
 
NOWA full length 
10mM CaCl2 
 
(5.6 ± 0.4)× 10-3 
 
  0.2 ± 0.1 
 
(3.2 ± 0.8)× 104 
 
(1.8± 0.5)×10-7 
  
 
(0.9 ± 0.3)×10-6 
 
  (0.6 ± 0.3)×107 
 
       CTLD  
(NOWA domain) 
 
(1.4± 0.1)× 10-2 
 
      n. a. 
 
(1.1 ± 0.1)× 104 
 
(1.3 ± 0.2)×10-6 
 
(1.1 ± 0.3)×10-6 
 
(0.8 ± 0.2)×106 
 
      MCRD  
(C-terminal domain of 
minicollagen) 
 
(5.9± 0.3)× 10-4 
 
      n. a. 
 
     240 ± 50 
 
(2.1 ± 0.6)×10-6 
 
      n. d. 
 
(0.4 ± 0.2)×106 
Table 1.  
Kinetic constants for binding of NOWA, C-type lectin domain of NOWA and C-terminal minicollagen cysteine 
rich domain to the model negatively charged (25% PG) membrane obtained from the evaluation of association 
and dissociation phases (I) and equilibrium binding data (II). 
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summarized in the table 1. Kinetic analysis in the above assumptions revealed affinity 
of single NOWA capsulomers to the membrane of 100nM. At the same time KD 
values calculated from the equilibrium isotherms were about 1µM. This contradiction 
is due to the presence of clusters that have much lower affinity to the membrane but 
much higher molecular mass reflected in the equilibrium SPR response signal. 
Consequently the affinity constants obtained from the equilibrium plots related rather 
to the strength of clusters – membrane association or surface clusters formation. At 
low initial protein concentrations (100 nM) either with or without calcium there are no 
high aggregates present in the solution and binding kinetics determined only by 
single capsulomers. Such curves were successfully fitted using a simple A + B = AB 
= A + B consideration and revealed the rate constants identical to those present in 
the complex model. The difference in the membrane affinity for NOWA capsulomers 
and their clusters is in good agreement with the cluster melting and diffusion towards 
the membrane during nematocyst morphogenesis. Once calcium concentration is 
dropped (increase in poly-?-glutamate concentration) the capsulomer precursor 
conglomerates melt, their membrane affinity rises ten times and they diffuse to the 
wall of the developing capsule. Another hypothesis arises from the diminished 
membrane affinity of NOWA conglomerates. One can speculate that cluster formation 
and membrane binding utilize the same protein domain thus aggregation process 
interferes with the capsulomer - membrane interaction. On the other hand once 
membrane surface is completely covered by capsulomers the same binding 
mechanism switched to the aggregation in order to add another wall layer. On this 
stage aggregation process must be accomplished by NOWA – mini-collagen disulfide 
isomerization. To specify the particular domain of NOWA responsible for the 
membrane binding we performed kinetic studies described below. 
 
Binding of NOWA domains to phospholipid bilayer.  
The membrane binding of two separate domains of NOWA – ONCRD (8 folded 
cysteine rich domain) and CTLD (C-type lectin domain) were examined by surface 
plasmon resonance. Both domains were shown to be structured after expression by 
CD in case of CTLD and electron microscopy in case of OMCCR. ONCRD 
recombinant constract was expressed without native C-terminal sequence of NOWA 
which carrying a strong positive charge. Figure 11 represents the results of 
 Figure 11 
A. Kinetics of NOWA, CTLD, and OMCCR binding to the 25% PG containing 
membrane measured by surface plasmon resonance. Molar concentrations of proteins 
were 1.5 µM. OMCCR exhibits no binding. B. Kinetic constants calculated using one to 
one model for the CTLD – membrane interaction shown for the particular curve of 0.5 
µM protein concentration. C. The C-terminal minicollagen cysteine rich domain 
(MCRD) – model membrane interaction. The peptide carring a native charged tail was 
injected in concentration of 38 µM. Calculated kinetic constants are indicated on figure. 
Red colour curve represents the fitting of association phase. 
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performed experiments with the domains binding to the lipid bilayers. Comparison of 
the association and dissociation kinetics of NOWA, CTLD and ONCRD to the 25% 
PG containing membrane measured by surface plasmon resonance is present on 
figure 11A. Molar concentrations of proteins were 1.5 µM equal for all samples. It is 
immediately obvious from the kinetics that CTLD binds to the membrane in contrast 
to the ONCRD exhibiting no binding. Kinetic constants for the NOWA CTLD – 
membrane binding determined using first order reaction model are summarized in the 
table 1. The membrane affinity of the C-type lectin domain is about 10 times smaller 
than that of NOWA. The association rate is slower and dissociation is more easily 
happening. Therefore one can conclude that CTLD even though contributing to the 
NOWA – membrane interaction does not take the whole responsibility. There must be 
additional mechanism involved. We assumed that higher affinity is due to the 
positively charged C-terminal sequence of NOWA which is most probably flexible and 
can lead to the electrostatic interaction of protein with the negatively charged 
membrane. The absence of ONCRD – membrane binding is a side evidence for this 
hypothesis. In order to check if charged tail – membrane interaction exist we 
performed the same type of experiments with the C-terminal cysteine rich domain of 
the minicollagen – 1 (MCRD). The structure of this domain was solved and will be 
discussed in details in the next chapter. We will also show in the following chapters 
that C-terminal MCRD revealed a new fold which is shared by NOWA cysteine rich 
domains. Therefore the MCRD can be considered as a model system for the last 
cysteine rich repeat of NOWA. We speculate here that the native C-terminal 
sequence of NOWA following the last cysteine rich repeat has structural and 
functional properties similar to those of the C-terminal tail of minicollagen. Direct use 
of the last NOWA cysteine rich repeat with the long native terminal sequence was 
more complicated because of the solubility problems. The MCRD of minicollagen 
showed strong binding to the model membrane as it was expected. Kinetic constants 
calculated from this experiment are also presented in table 1. Characteristic 
association/dissociation kinetic of MCRD to the 25% PG bilayer is shown on the 
figure 11C. In contrast to MCRD single NOWA cysteine rich domain had no 
membrane affinity though it has very similar structure including C-terminal flexible tail. 
The only difference between these two peptides is the charge of their tail residues: in 
case of NOWA peptide tail carries no charge. Schematic representation of NOWA 
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cysteine rich domain structural organization, summarized membrane binding 
properties of investigated molecules and alignment of the C-terminal sequences of 
NOWA and minicollagen – 1 are presented on the figure 12.  
Concluding the results of this chapter we showed that recombinantly expressed 
NOWA exhibits binding to the negatively charged model lipid membranes. This 
binding is strong for single capsulomer-like NOWA globules and becomes weaker for 
higher aggregates. C-type lectin domain of NOWA was shown to participate in the 
membrane binding although additional mechanism is required to accomplish the 
strength of full-length protein interaction. This additional mechanism is proposed to 
be due to the electrostatic interaction of C-terminal positively charged NOWA 
sequence with negatively charged surface of lipid membrane. 
 A
B 
C-terminal of NOWA - 
CSLQQPGCSSACAPACRLSCCSLGRMNLGRKRSHVHHKKLKASRKKKQSKA 
CPPV        CVAQCVPTCPQYCCPAKRK 
C-terminal of Minicollagen-1 
Figure 12. 
A. Schematic drawing of the hypothetical domain organization of the NOWA cysteine 
rich domain and CTLD with and without positively charged C-terminal sequence. 
The scheme summarizes membrane binding properties found for the NOWA 
protein and for the domains of NOWA and minicollagen. We claim that NOWA –
membrane interaction is due to both C-type lectin domain and charged C-terminal 
sequence of the protein. 
B. Aligned sequences of the very C-terminal cysteine rich repeat of NOWA and C-
terminal CRD of minicollagen. Positively charged residues colored in red and 
cysteines colored in green.  
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Abstract 
The minicollagens found in the nematocysts of Hydra constitute a family of 
invertebrate collagens with unusual properties. They share a common modular 
architecture with a central collagen sequence ranging from 14-16 Gly-X-Y repeats 
flanked by polyproline / hydroxyproline stretches and short terminal domains that 
show a conserved cysteine pattern (CXXXCXXXCXXXCXXXCC). The 
minicollagen cysteine-rich domains (MCRD) are believed to function in a switch of 
the disulfide connectivity from intra- to intermolecular bonds during maturation of 
the capsule wall. The solution structure of the C-terminal fragment including a 
MCRD of minicollagen-1 was determined in two independent groups by 1H NMR. 
The corresponding peptide comprising the last 24 residues of the molecule was 
produced synthetically and refolded by oxidation under low protein concentrations. 
Both presented structures are identical in their fold and disulfide connections 
(Cys2-Cys18, Cys6-Cys14, Cys10-Cys19) revealing a robust structural motif that 
is supposed to serve as the polymerization module of the nematocyst capsule. 
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Introduction 
Minicollagens of nematocysts in Hydra, corals and other cnidaria are very 
unusual proteins with structural properties not shared by other invertebrate or 
vertebrate collagens. From both the N- and the C-terminus of the collagen triple 
helix emerge three polyproline-II-type helices, which consist of 5 to 23 proline or 
hydroxyproline residues (1-3). Each of the PPII-helices is terminated by a small 
Cys-rich domain, termed minicollagen Cys-rich domain (MCRD). The N- and the 
C-terminal MCRDs are homologous and share the cysteine pattern 
CXXXCXXXCXXXCXXXCC. A small propeptide region preceding the N-terminal 
MCRD is cleaved off during expression, and mature minicollagen has a rather 
symmetrical appearance with closely similar structural elements at both sides. This 
bipolar nature of minicollagen is unique among all other known collagens (4-7) and 
suggests a special function. 
A unique function of minicollagen is also suggested by its restricted 
appearance in the capsule wall of nematocysts. Nematocysts are complex 
explosive organelles, which basically consist of a capsule, an inverted tubule 
armed with spines and an operculum. The tubule is connected to the capsule wall 
and is twisted in many turns inside the osmotically charged capsule matrix. 
Following stimulation, the internal tube is expelled, the osmotic pressure is 
released and capsule contents including toxins are released at the tubule end. 
This specialized form of exocytosis proceeds with ultra-fast rates and 
accelerations comparable to those of a fired bullet (8). 
The capsule wall resists more than 150 atmospheres of osmotic pressure in 
the charged state. For Hydra nematocysts it consists mainly of two proteins: 
minicollagen and nematocyst outer wall antigen (NOWA) (9-11). The two proteins 
can be dissolved from capsule preparations only under reducing conditions. 
Already at a time at which the amino acid sequence of minicollagens was 
unknown it was found that these collagens formed disulfide cross-linked polymers 
that were insoluble in SDS but easily soluble in the presence of a reducing agent 
(12,13). Following the discovery of a family of minicollagens (3) and recombinant 
expression of minicollagen-1 (9) it was found that the proteins are expressed in a 
soluble precursor form present in the endoplasmatic reticulum and post-Golgi 
vacuoles in Hydra. They are converted to the disulfide linked assembly form of the 
nematocyst wall upon wall compaction, during which a dense and well-defined 
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capsule wall is formed (9). The morphological changes, a loss of accessibility to 
antibodies against minicollagen-1 and a parallel loss of solubility under non-
reducing conditions suggested a close link between disulfide polymerization and 
the condensation of wall proteins. Both processes provide an explanation for the 
unusually high tensile strength of the mature nematocyst wall.  
Minicollagen-1 of Hydra recombinantly expressed in mammalian cells 
contains internal disulfide bonds in its MCRDs but no interchain disulfide cross-
links between chains (9). The trimeric collagen molecules dissociated into single 
chains when heated to 45°C under non-reducing conditions (10). Reduction did 
not influence this transition temperature indicating that only the collagen domain is 
responsible for trimerization. Recombinant minicollagen-1 was found to form 
aggregates in electron micrographs but no disulfide bridges were formed 
spontaneously under in vitro conditions (9). This material behaved like the 
precursor form in vivo and could be solubilized by SDS or other denaturants under 
non-reducing conditions. It was therefore concluded that disulfide isomerases or 
other external parameters are required for a disulfide reshuffling process by which 
internal disulfide bridges are converted to intermolecular links (14). 
More recent results suggest, that the structural function of minicollagens in 
wall hardening is complemented by NOWA (11). Altogether ten domains were 
identified in this protein, namely a SCP-domain (smart00198), a C-type lectin 
domain (CTLD, smart00034) and 8 C-terminal domains with homology to the 
MCRDs. In particular, the pattern of six cysteines is shared by the corresponding 
domains in NOWA and minicollagen. The presence of homologous Cys-rich 
domains in both proteins suggested a joint function in disulfide-mediated 
polymerization. Supportive evidence was obtained by analysis of breakdown 
products of native nematocyst capsules after limited sonification without reduction 
(Özbek et al., in preparation). Minicollagen and NOWA formed disulfide cross-
linked units that like the entire capsule were readily dissolved under even mild 
reducing conditions. 
Disulfide reshuffling processes and formation of disulfide-linked complexes 
are common mechanisms in the extracellular space and some recently explored 
systems may be referenced (15-19). The minicollagen/NOWA system may stand 
as a prototype for the controlled formation of a highly stable matrix layer by 
disulfide linkage. To understand the assembly mechanism, the 3-dimensional 
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structure of the MCRDs involved is needed. The core of the MCRD consists of 
only 20 residues with 6 closely positioned Cys residues. At the start of this work it 
was not known whether the very small domains were autonomous or stable only 
as part of a larger structure. The disulfide connections were also not known and 
could not be explored by limited proteolysis because of the lack of suitable 
cleavage sites. These problems were approached by solving the structure of the 
C-terminal Cys-rich domain of minicollagen-1 by NMR spectroscopy. A new fold 
was found, with disulfide connections between Cys-2 and Cys-18, Cys-6 and Cys-
14, and Cys-10 and Cys-19. Oxidative folding occurs at high rates in the presence 
of a GSSG/GSH redox buffer with formation of almost exclusively one single 
isomer. A highly conserved Pro residue located between Cys-10 and Cys-14 
induces and probably directs correct disulfide connections. The presented 
structure proposes likely candidates for disulfide reshuffling supposed to be a key 
reaction during nematocyst morphogenesis. 
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Experimental Procedures  
 
Peptide Synthesis and oxidation 
Preparation 1 
The 6xStBu protected peptide Ac-PCPPVCVAQCVPTCPQYCCPAKRK-NH2 
was synthesized on Fmoc-Rink-Amide PEGA resin by the Fmoc/tBu strategy using 
double couplings with Fmoc-Xaa-OH/HBTU/HOBt/DIEA (4:4:4:8), intermediate 
Fmoc cleavage with 20 % piperidine in DMF and acetic anhydride/DIEA (4:8) for 
N-terminal acetylation. After resin cleavage/deprotection with 
TFA/phenol/H2O/thioanisole/1,2-ethanedithiol (82.5:5:5:5:2.5) the product was 
isolated by RP-HPLC; yield: 6 %; HPLC: tR = 12.5 min (>98 %); ESI-MS: m/z = 
1055.0 [M+3H]3+; 1581.8 [M+2H]2+; Mr = 3162.31 calculated for C136H230N32O29S12. 
The Cys protecting groups were cleaved in TFE/H2O with tributylphosphine (60 
equiv) at RT for 5 h and the resulting fully deprotected peptide was oxidized at pH 
8.0 in the presence of GSSG/GSH (9 equiv, 10:1) under air atmosphere at 7 °C. 
The crude product was purified by preparative size exclusion column 
chromatography; yield: 20 %; HPLC: tR = 12.3 min (>98 %); ESI-MS: m/z = 1314.8 
[M+2H]2+, 876.4 [M+3H]3+; Mr = 2627.23 calculated for C112H176N32O29S6. 
 
Preparation 2 
The linear peptide was synthesized with an ABI 433A synthesizer. Couplings 
were carried out on a Fmoc-Lys(Boc)-PEG-PS resin (Perseptive Biosystems, 0.21 
mmol/g) using Fmoc-amino acids (Fmoc-Arg(Pbf), Fmoc-Lys(Boc), Fmoc-Tyr(tBu), 
Fmoc-Cys(Trt), and Fmoc-Gln(Trt)) (Anaspec). HATU (O-(7-azabenzotriazol-1-yl)-
1.1.3.3-tetramethyluronium hexafluorophosphate, (Perseptive Biosystems) (4.0 
eq.) / Diisopropylethylamine mediated peptide couplings. The peptide was cleaved 
from the resin with trifluoroacetic acid, containing thioanisol (5 % v/v), ethanedithiol 
(3 % v/v), and anisole (2 % v/v). After precipitation in diethylether, the crude 
peptide was purified by preparative HPLC (Vydac® C18, 10-15m, 300Å, 250 x 50 
mm, W.R. Grace, MD, USA). The peptide was characterized by electrospray 
ionization/quadrupole/time-of-flight mass spectrometry and amino acid analysis. A 
mass of 2590.9 Da was determined and the expected amino acid composition was 
found. 
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The lyophilized purified peptide was dissolved in 25 mM Tris/HCl, pH 6.0, 
containing 100 mM NaCl at a concentration of 0.02 mM. Folding was allowed to 
proceed under N2 for 72 to 96 hours at 4 oC. Oxidation was induced by changing 
the pH to 8.0-8.1 with saturated Tris, and the addition of reduced and oxidized 
glutathione (10:1 molar ratio) to a final concentration of 1 mM. The solution was 
exposed to air at 4 oC for four to ten days. Oxidation was stopped by the addition 
of trifluoroacetic acid to give a pH of 1.3. The oxidized peptide was purified by 
preparative HPLC. The yield of oxidized peptide was 103 mg (16 % of theoretical 
yield). Mass spectroscopy of the oxidized peptide showed a molecular mass of 
2585.1 Da. 
 
NMR Data Collection 
Structure 1 
NMR experiments for conformational analysis were carried out at 283 K on 
Bruker DRX500, DMX750 and DX900 spectrometers using a 3 mM sample of the 
peptide dissolved in H2O/D2O (9:1) mixture at pH 3.5. Resonance assignments 
were performed according to the method of Wüthrich (38). 173 experimental 
interproton distance constraints were extracted from 2D-NOESY (39) experiments 
with mixing times between 75 and 200 ms. Five hydrogen bonds were identified 
from temperature shifts and H/D exchange. Acceptor carbonyl groups were 
identified in initial structure calculations. The NOE intensities were converted into 
interproton distance constraints using the following classification: very strong (vs) 
1.7-2.3 Å, strong (s) 2.2-2.8 Å, medium (m) 2.6-3.4 Å, weak (w) 3.0-4.0 Å, very 
weak (vw) 3.2-4.8 Å and the distances of pseudo atoms were corrected as 
described by Wüthrich (38). Distance geometry (DG) and molecular dynamics-
simulated annealing (MD-SA) calculations were performed with the INSIGHTII 
98.0 software package (Accelrys, San Diego, CA) on Silicon Graphics O2 R5000 
computers (SGI, Mountain view, CA) as described recently (25). In brief, hundred 
structures were generated by distance geometry and refined with MD-SA steps. 
The experimental constraints were applied at every stage of the calculations. The 
coordinates and structural restraints have been deposited in the Brookhaven 
Protein Data Bank under accession number 1SOP. 
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Structure 2 
Chemically synthesized C-terminal MCRD of minicollagen-1 was purified after 
oxidation according to purification procedure 2. The determination of the NMR 
structure (PDB accession number 1SP7) was carried out in 5 mM sodium 
phosphate buffer, pH 6.5 at 15°C by using homonuclear and heteronuclear 
techniques and information from weak alignment. Details of this structure 
determination will be published separately. Structure representations were 
generated with MOLMOL (43). 
 
Analytical ultracentrifugation 
Sedimentation equilibrium experiments were performed on a Beckman 
Optima XL-A analytical ultracentrifuge (Beckman Instruments) equipped with 12-
mm Epon double-sector cells in an An-60 Ti rotor. The MCRD was analyzed in 
5mM Tris buffer (pH 7) without salt or containing 100 mM NaCl at 20°C. The 
peptide concentrations were adjusted to 0.2-0.8 M. Sedimentation equilibrium 
scans were carried out at 48,000 rpm. Molecular masses were evaluated from lnA 
versus r2 plots, where A is the absorbance at 277nm and r is the distance from the 
rotor center. A partial specific volume of 0.73 ml/g was used for all calculations. 
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Results 
 
The MCRD constitutes a conserved sequence module in nematocyst 
minicollagens and in NOWA 
The sequence of minicollagen–1 with domain indications and alignment of 
cysteine-rich domains from different minicollagens and NOWA are represented in 
Figure 1. Minicollagen-1 consists of an N-terminal MCRD, N-terminal polyproline 
region, a central collagen sequence, a shorter C-terminal polyproline stretch 
followed by a C-terminal MCRD (Fig. 1A). The preceding propeptide is cleaved off 
during recombinant expression of minicollagen-1 and probably also in Hydra (9). 
As already mentioned in the introduction the overall sequence homology of the 
Cys-rich domains is not very high but the cysteine pattern is identical for all 
minicollagens and for the eight C-terminal domains of NOWA with the only 
variation being in the number of residues spacing the first two Cys residues. The 
sequence of the C-terminal minicollagen-1 MCRD, which has been investigated in 
the present work, is underlined and the numbering of residues corresponds to the 
synthetic peptides used in this study. Beside the cysteines there is only one 
conserved residue, which is Pro12 (shown in purple in Fig. 1B). 
 
Peptide synthesis and oxidation 
As the MCRD occurs in different molecular contexts, at the N- and C-terminal 
extensions of minicollagen molecules as well as eight times repeated at the C-
terminus of NOWA, we speculated that it might constitute an isolated domain with 
the capacity of independent folding. Peptide synthesis was carried out for the C-
terminal MCRD of minicollagen-1 starting with the last proline residue of the C-
terminal polyproline stretch and including the charged C-terminus of the full-length 
molecule. The formation of disulfide bonds occurs in the presence of redox buffer 
at 100 µM peptide concentrations to avoid aggregation by intermolecular disulfide 
bonds (see Experimental Procedures). The final product showed a single peak in 
mass spectroscopic analysis with the reduced and oxidized MCRDs having a 
difference in molecular weight of 6 Da, thereby strongly indicating the formation of 
three intramolecular disulfide bonds (Table I). Disulfide bonds can be shown to be 
all-intramolecular in mass spectroscopic analysis. Analytical ultracentrifugation 
confirmed the absence of significant aggregation or multimerization in solutions 
A 
 
Minicollagen-1 
 
propeptide   N-Cys-rich    poly-Pro 
 
KTLHEMLKRDANPCGSYCPSVCAPACAPVCCYPPPPPPPPPPPPPPPPPPPPPPPAPLP 
   
collagenous        poly-Pro     C-Cys-rich  basic tail 
 
GNPGPPGRPGPPGAPGPAGPPGLPGPPGPPGAPGQGGLPGQPAPPPPPCPPVCVAQCVPTCPQYCCPAKRK 
 
B 
 
N- and C- terminal Cys-rich repeats of minicollagens (MCol) and NOWA (NW) 
 
      1   10   20   
MCOL1hN  DANPCGS   YCPSVCAPACAPVCCYPPPPPPPPPPPPPPP 
MCOL2hN   SAQACGY   NCPAICAPACTPICCAPPPPPPPPPPPPPPP   
MCOLadN  CGY   GCPSMCAPACEPTCCAPPPPPPPPP    
MCOLapN REASPCGY   GCPSMCAPACEPTCCAPPPPPPPPP 
MCOLacN REASPCGY   GCPSMCAPACEPTCCAPPPPPPPPP 
MCOL1hC PPPPPCPP   VCVAQCVPTCPQYCCPAKRK     
MCOL2hC PPPPPCPP   ICPTQCVPYCPQYCCLKGPPGPP     
MCOLadC  PPPPCPP   ICIQHCIRICPQPCCSPPPPP     
 
NOhREP1  QITGTCPS   GCSGDCYPECKPGCCGQVNLNAPVQP    
NOhREP2  SGYTACSQ YPNCGLSCQSSCSQSCCQQNPYQPSVMSGTIVIQP    
NOhREP3  NEQSVCPQ HPGCSQHCAPRCSPQCCQQSMNSLYQP    
NOhREP4  PQMSACPQ FPSCSPTCAPQCSQLCCQQSSMPLQM   
NOhREP5  PQMPSCPQ FPSCSASCAPQCSQQCCQQPSMSIQP   
NOhREP6 LQISSCPQ FPSCSPSCAPQCSQQCCQQPSMPIQL   
NOhREP7  PLMGSCSQ MPGCSASCAPLCSQQCCQQQAMLQQSIMQQPMM   
NOhREP8  MAQNPCSLQQPGCSSACAPACRLSCCSLGRMNLGR   
 
Figure 1. 
 A, minicollagen-1 amino acid sequence and domain structure. Propeptide sequence is 
in blue, MCRDs in red, polyproline sequences in light green, collagen repeat in dark 
green. B, Alignment of MCRDs in minicollagen molecules from different cnidarians and 
in NOWA. MCol1h: minicollagen-1 Hydra, MCol2h: minicollagen-2 Hydra (3), MColad: 
minicollagen Acropora donei (2), MColac: minicollagen Acropora cervicornus (1),
MColap: minicollagen Acropora palmate (1), N, C: N-, C- terminal, The sequence of the 
Cys-rich region of NOWA in Hydra (NWh) starts with repeat 1 and terminates with repeat 
8. Residues in MCol1hC are numbered starting at proline preceding the first cysteine 
and the same numbering was used in the NMR structures. The highly conserved 
cysteine residues are marked in red. Proline in position 12, which is conserved with two 
exceptions, is marked in purple. The sequence of the synthesized and investigated 
peptide is underlined. 
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from 0.2 to 0.8 mM total peptide concentration (Table I), which was further 
supported by NMR 1HN T2 relaxation times of more than 100 ms at 25 °C, 
indicative of the prevalence of a monomeric state in solutions of 1.6 mM MCRD. 
 
The NMR Structure of the MCRD 
The solution structure of the MCRD was determined independently by a 
group in Basel and Munich (see affiliations in the author list) from two separate 
peptide preparations (see Experimental Procedures). Both structures show an 
identical tightly packed globular fold (Figures 2 and 3), which consists of a short N-
terminal α-helix between Val5 and Gln9 followed by an inverse γ turn (Gln9-Val11), 
a type I β turn (Val11-Cys14) and a type III β turn (Pro15-Cys18). Thus cysteines 
6, 10, 14 and 18 are directly located in turns whereas cysteine 2 is located in a 
proline-rich N-terminal sequence and cysteine 19 is oriented presumably by the β 
III turn and a C-terminal proline. All proline residues in the MCRD are in trans 
conformation as evidenced by specific NOEs. 
The only conserved residue Pro12 (Fig. 1) imposes a β I turn topology on 
residues 11 to 14 due to its fixed ϕ angle of –60 °. Hydrogen bonds are 
established in the turns between Val5 (O) and Gln9 (HN), Gln9 (O) and Val11 (HN), 
Val11 (O) and Cys14 (HN), and Pro15 (O) and Cys18 (HN) (Fig. 3), respectively, as 
derived both from the calculated structures and from the slow 1H/D exchange upon 
lyophilization of MCRD and redissolving in 2H2O. The positively charged C-
terminus Lys22, Arg23, Lys24 is flexibly disordered and does not contribute to the 
MCRD structure (Fig. 2). 
The first disulfide bond, Cys2-Cys18, clasps the N- and C-termini of the 
domain while the Cys6-Cys14 bond connects the N-terminal α-helix to the type I β 
turn starting with Val11, thus forming the core of the MCRD structure. The third 
disulfide bond Cys10-Cys19 is more exposed to the C-terminal surface of the 
domain and constrains the polypeptide backbone into two consecutive turns. The 
more surface-exposed N- and C-terminal disulfide bridges represent the most 
likely candidates for intermolecular disulfide exchange reactions. Complete 
reduction of the disulfide bonds with an excess of tris(2-carboxyethyl)-phosphine 
hydrochloride (TCEP) at pH 7.5 results in complete unfolding without retainment of 
local conformational preferences as well assessed by 1H NMR. 
 Figure 2.  
NMR structures of the C-terminal MCRD of minicollagen-1. The backbone is 
displayed in blue, side chains in red except for cysteine side chains in yellow. 
Structure 1 (left, accession number: 1SOP): the ten energy lowest structures 
are superimposed using the backbone atoms of residues 2-19 with an rmsd of 
0.6 Å. Disordered residues 21-24 are depicted in grey. Structure 2 (right, 
accession number: 1SP7), all-heavy-atom representation of the 20 lowest 
energy conformers of the minicollagen-1 C-terminal MCRD out of 100 structures 
calculated in CNS (42), with best fit for backbone heavy atoms of residues 2-21. 
The charged C-terminal sequence K22R23K24 (grey) is disordered at pH 6.5 in 
the absence of additional salt.  
 
 Figure 3.  
Stereoview of the same conformer as in Figure 2 in ribbon presentation. Only 
structure 2 is shown. Cysteines and disulfide bonds are shown in yellow and 
Pro12 is in aquamarine. Disulfide bonds (Cys2-Cys18, Cys6-Cys14 and Cys10-
Cys19) as well as the conserved Pro12 are indicated in ball and stick 
representation. Dashed lines indicate the hydrogen bonds identified by 
MOLMOL. These are bonds between Pro5 (O) and Gln9 (HN); Val11 (O) and 
Cys14 (HN); Pro15 (O) and Cys18 (HN). The first two H-bonds belong to the α–
helix, others belong to the three different turns. Pro12 induces a βI turn from 
residues 11 to 14. All proline residues in the structure can be shown to be in 
trans conformation from experimental NOE distance information. 
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Reoxidation of reduced MCRD with an excess of oxidized glutathione at pH 
7.5 proceeds extremely fast and is completed within 2 hours as observed by 1H 
NMR spectroscopy (Fig. 4). This is presumably due to the small domain size and 
the effect of Pro12 upon disulfide bridge formation (see discussion). Fluorescence 
spectroscopy allows monitoring of the refolding due to the quenching of Tyr17 
fluorescence by a nearby disulfide bridge and yields a folding half time of 1.5 
hours at pH 8 upon oxygen saturation of the solution in agreement with NMR data 
(not shown). 
 
Model of trimeric minicollagen-1  
It has already been mentioned that minicollagen-1 at native conditions 
appears to be a non-covalent trimer. A schematic representation of the trimeric 
minicollagen molecule including the connections of N- and C-terminal MCRDs to 
the polyproline type II helices is shown in Figure 5. A model of trimeric 
minicollagen-1 was proposed earlier (9) in which the MCRD was assumed to have 
a linear structure. After elucidation of the structure of the MCRD we are now able 
to draw a schematic model in scale with the known dimensions of the collagen 
triple helix and the polyproline-II helix (4). An open question is the geometry of the 
connections between the collagen and polyproline parts of the molecule and 
between MCRDs and polyprolines, respectively. The angles and flexibility at the 
junction sequence APLP in the N-terminus and the single Ala spacer in the C-
terminus (Fig. 1, shown in black) or by any Pro residue that potentially can occur in 
cis conformation are not known. The lack of association between MCRDs even at 
relatively high concentrations would suggest that they also do not associate in 
minicollagen without the help of an isomerase or another catalytic system. 
Polyproline or polyhydroxyproline-II helices are also known to be monomeric. For 
these reasons the polyproline arms with their MCRD heads are displayed as non-
interacting entities in Fig. 5. This is confirmed by previous biochemical data 
showing that minicollagen-1 trimers are not disulfide-crosslinked and the triple 
helix is stabilized solely by the collagen sequence composition (10). 
The ways that MCRDs are linked to the main molecule are shown 
schematically (red arrows) in the upper (N-terminal) and the lower (C-terminal) 
part of Figure 5. The polyproline-II helices approach the MCRDs from the N-
terminus for the C-terminal domain and from C-terminus for the N-terminal 
 Figure 4.  
Folding kinetics of the MCRD as monitored by NMR. The intensity of the 
amide resonance signal of Val5 in folded MCRD is shown upon reoxidizing 
fully reduced MCRD with an excess of oxidized glutathione. The reoxidation 
reaction is completed within 2 hours at pH 7.5 when catalyzed by the 
glutathione system. The unusually fast reoxidation is in agreement with data 
from fluorescence experiments (data not shown). 
 
 Figure 5.  
Schematic presentation of the minicollagen-1 trimer. Full-length minicollagen-1 
(central part of the figure) and connections of polyproline regions to MCRDs 
(upper and lower parts of the figure) are shown. Yellow circles and ribbon 
globular structures are MCRDs; blue lines and blue ribbons – polyproline type II 
helices (PP); red lines – collagen triple helix. Basic tails of the C-terminal MCRDs 
are represented in faint curves. In the upper part only the MCRD core (2-21 
residues) is shown. The connection to the N-terminal 23 residue polyproline helix 
is indicated by a red arrow. 
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domain. The connections between the polyproline-II helices and the MCRD might 
alter the accessibility of particular disulfide bridges in the MCRD. As can be seen 
from comparison of Figures 3 and 5, in the N-terminal MCRD the Cys10 – Cys19 
disulfide is less exposed. An opposite situation is observed in the C-terminus 
where the polyproline-II stretch hides the Cys2 - Cys18 bridge. Accordingly the 
suggested candidates for intermolecular disulfide exchange are Cys2-Cys18 for 
the N-terminal and Cys10-Cys19 for the C-terminal MCRD. 
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Discussion 
 
Small Cys-rich domains are widely distributed building blocks of extracellular 
proteins in essentially all phyla including plants and bacteria. The most abundant 
domain type is the epidermal growth factor domain (EGF, smart00181). Including 
its variants EGFca (smart00179) and EGF-like (smart0001) several thousands of 
different EGF-domains are known in proteins of different functions (see Smart 
database, http://smart.embl-heidelberg.de). In most cases EGF-domains are 
arranged in arrays with other domains. Laminin (20) and fibrillin (21) are two out of 
very many examples. Many Cys-rich domains, however, also exist as single 
autonomous proteins and the epidermal growth factor domain is a well-known 
example. This fact provides a bridge to the numerous low-molar mass Cys-rich 
proteins, which are also products of larger precursor forms but express their 
function as toxins, antimicrobial peptides or other small bioactive agents. 
Variations of sequences, cysteine patterns and three-dimensional structures are 
however very large for this diverse class of small proteins and clear homologies 
exist for small groups only (22). Small Cys-rich peptides with antimicrobial or toxic 
functions are part of the innate immunity and defense system of invertebrate 
animals. They are often stored in secretory granules and released in response to 
parasites via exocytosis. Nematocyst discharge in cnidarians represents a 
specialized form of exocytosis from a giant post-Golgi vesicle. The appearance of 
a structural motif related to Cys-rich peptide toxins in proteins involved in the 
formation of a wall polymer, which is associated with the nematocyst membrane, 
might hint at a phylogenetic link between this group of defensive molecules and 
the evolution of the nematocyst. 
The common feature of small Cys-rich domains is the prevalence of disulfide 
bridges in structure stabilization. This is already suggested by the large fraction of 
cysteines, which is 4/22 for gomesin (23), about 6/40 for EGF domains, 8/42 for 
crambin (24) and hellethionin (25) as compared to 6/20 for the Cys-rich domain of 
minicollagen-1. The later domain has one of the highest ratios of cysteines to total 
residues known so far. Comparably dense cysteine patterns are only described for 
small conotoxin peptides like PnIVA and PnIVB (26). The peptide whose structure 
was elucidated in the present work is 4 residues longer than the essential core. 
The structure shows that the first proline and the last three residues are randomly 
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oriented and probably not required for correct oxidative folding. The remaining 
structure is well defined and data demonstrate formation of a single topoisomer 
under optimized oxidative conditions. 
In the reduced state no conformational preferences were found in MCRD by 
NMR. Similar observations were reported for many other Cys-rich domains 
underlining the importance of disulfide bonds for stabilization. As shown for 
tachyplesin mutational replacements of Cys- residues by alanine lead to a loss of 
structure (27). Interestingly the global fold of tachyplesin was rescued by 
hydrophobic interactions between pairs of tyrosines or phenylalanines if cysteines 
were replaced by these residues (27). 
Although the equilibrium structure of MCRD is predominantly determined by 
the covalent interactions between Cys residues kinetic intermediates must be 
responsible for correct disulfide pairings. A folded-precursor mechanism 
(28,29,36) and a quasi-stochastic mechanism (30,31) were proposed for other 
monomeric proteins. True pathways are probably between these two extremes. 
For the Cys-rich domain of minicollagen formation of a type I  turn by Pro12 and 
hydrogen bonding between Cys14 (HN) and Val11 (O) is most likely a very 
important intermediate step. As can be seen from the structure (Figs. 2 and 3) this 
bend and the  turn bring the cysteines into close vicinity for correct intramolecular 
disulfide bridging. 
It is amazing that few non-covalent interactions in the MCRD of minicollagen 
and in many other short peptides lead to correct connectivities between several 
Cys residues, which statistically could also interact in very many different intra- 
and intermolecular modes. To establish the disulfide connections of MCRD 
pairwise bridges between adjacent Cys-residues have to be prevented. The three 
intervening amino acid residues found in MCRDs render pair-wise bridges 
unfavorable (32) and this feature is most likely essential for proper folding. 
In small disulfide rich proteins identical folds are found in homologous 
domains in contrast to large variations in non-cysteine residues. A striking 
example are the about 200 solved structures of different EGF-domains, which 
exhibit the same fold although sequence identities of non-cysteine residues are 
difficult to detect (smart, key words EGF and structure). This high conservation of 
structure leads us to assume, that the related Cys-rich repeats in minicollagen of 
corals and in NOWA proteins have the same global fold as the MCRD of 
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minicollagen-1 of Hydra, which was investigated in the present work. Conservation 
of residues is low (Fig. 1) and would not allow the prediction of structure identities 
for conventional globular proteins (33)  
Earlier data on the interaction of minicollagens and NOWA in the nematocyst 
wall conclusively demonstrated a switch from a soluble state of both proteins with 
all disulfides internally linked to an insoluble dense polymeric state with 
intermolecular disulfide bonds (see introduction). Analogous assembly processes 
involving disulfide reshuffling were reported for virus capsid proteins (19), collagen 
IV (34) and other systems (17,18). The only cysteines in minicollagen-1 are 
located in the MCRDs. Consequently a disulfide reshuffling interaction was 
proposed between these domains. The data also suggested corresponding 
interactions between the Cys-rich domains of minicollagen and NOWA. In vivo the 
situation may be rather complex because of possible interactions between N- and 
C-terminal domains of different minicollagens in the same organism. At each end 
of a minicollagen three MCRDs are present (Fig. 4). This opens the possibility of a 
simultaneous interaction between minicollagens and NOWA. 
Extensive searches of the database failed to reveal MCRD-like domains in 
non-nematocyst proteins. The domain type seems to be highly specialized for 
disulfide mediated crosslinking of the nematocyst wall. For several organisms with 
nematocyst organelles minicollagen and NOWA genes have been found but 
sequencing of cnidaria genes is still too incomplete to allow a general conclusion. 
Interestingly in minicollagen of corals (AF507373.1) Cys-residues frequently occur 
after glycines in the collagenous part of the sequence. Cysteine residues, which 
interlink collagen chains of the same molecule are located at the ends of a triple 
helix to form a stable disulfide knot (35,36) or located in interruptions of the regular 
Gly-X-Y repeat (37). Cys-residues in X-position of collagens are highly unusual 
and are most likely used to link between collagen molecules. It may be speculated 
that the nematocyst walls of corals are cross-linked by disulfide bridges between 
collagen triple helices in addition to those between MCRDs thus providing a higher 
tensile strength. 
Future work will focus on the mechanism of the disulfide reshuffling process 
using isolated Cys-rich domains of minicollagen and NOWA. A likely possibility is 
the interaction between N-and C-terminal domains of minicollagens. In vivo, the 
disulfide exchange reaction probably is catalyzed by disulfide isomerases or other 
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helper proteins, which have to be defined prior to in vitro studies. Our working 
hypothesis is that only one or two out of the three disulfide bonds will be reshuffled 
from intra to intermolecular. Likely candidates are the bonds Cys2-Cys18 and 
Cys10-Cys19, which are both surface exposed. 
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The structure of the first cysteine rich repeat of NOWA cysteine 
rich domain. 
Fluorescence study of oxidative refolding. 
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Abstract 
The solution structure of the first cysteine rich repeat of Hydra nematocyst wall 
protein NOWA (NCRD1) has been determined using homonuclear and 
heteronuclear NMR techniques at natural abundance. The domain consists of 
25 amino acids with the cysteine pattern identical to that of the minicollagen-1 
cysteine rich domains (MCRD). Except the cysteines and Pro12 overall amino 
acid composition of the investigated peptide has no homology to the MCRD. In 
the present study we demonstrate that NCRD1 has disulfide pattern identical to 
that of the MCRD. Moreover NOWA domain exhibits overall structure topology 
similar to the topology of minicollagen domain and therefore can be classified 
as the same fold. The C-terminal minicollagen-1 and the first NOWA cysteine 
rich domains both revealed the effect of tyrosine fluorescence quenching by 
disulfide bonds although the tyrosine positions are different within the domains. 
The oxidative refolding has been monitored using the fluorescence of single 
tyrosine residue for both peptides. Resulting kinetics could be fitted with single 
exponential suggesting a simple kinetic mechanism that arises from the 
quenching by only one particular disulfide bond. We propose that quenching 
occurs due to the Cys2-Cys18 bond in case of MCRD and Cys6-Cys14 in case 
of NCRD1. Oxidation and reduction rate constants differ in values according to 
the susceptibility of the disulfide bridge responsible for the fluorescence 
quenching. 
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Introduction. 
 
Cysteine rich domain of NOWA exhibit the same structural fold as the C-
terminal minicollagen-1 cysteine rich domain.  
Two major proteins of nematocyst capsule wall, NOWA and minicollagen, 
share common cysteine rich domain (CRD) (1). This domain appears two times 
in minicollagen (see schematic representation of the minicollagen trimer on the 
figure 4 of chapter 3) and eight times in the NOWA protein (Fig. 1, sequence 
alignment). The 8-folded cysteine rich domain of NOWA termed ONCRD (octad 
NOWA cysteine rich domain) follows the C-type lectin domain of the protein 
and continues up to the basic C-terminal sequence. The structure of 24 amino 
acid peptide comprising C - terminal domain of minicollagen-1 has been 
recently solved (see chapter 3 for details). We have also proposed that 
regardless the low sequence homology among the cysteine rich repeats in the 
nematocyst proteins they all share identical disulfides connectivity and overall 
structural fold. Nonetheless there were no experimental evidences present for 
that. Here we report the structure of chemically synthesized first cysteine rich 
repeat of NOWA. Hereafter we refer to this peptide as NCRD1 (NOWA cysteine 
rich domain 1). This particular domain has very low homology to the previously 
solved MCRD peptide except the cysteines and the conserved Pro12 residue 
(Fig. 1). The Pro12 was discussed to be an important feature for the correct 
disulfide connectivity and overall structure formation of MCRD. According to the 
elucidated structure of NCRD1 cysteines connectivity found in C-terminal 
minicollagen cysteine rich domain are preserved. Furthermore both peptide 
structures have overall similar topology. These data strongly support the 
previous speculation that MCRD structure is a general fold for Hydra 
nematocyst wall proteins. Furthermore oxidative refolding of investigated 
peptides has been studied using intrinsic fluorescence of tyrosine in position 17 
for MCRD and 11 for NCRD1. 
 
Intrinsic tyrosine fluorescence quench as a tool to study oxidative protein 
folding. 
Intrinsic fluorescence of the aromatic amino acids in proteins is a sensitive 
but at the same time very limited tool to study protein folding. Fluorescence 
changes arise from conformational and environmental changes. Sensitivity can 
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easily become a disadvantage. An enormous number of factors can influence 
protein fluorescence therefore making it impossible to understand what factor is 
the major player. Fortunately there are exceptions with simplified situations. 
Those are proteins containing single tryptophan or tyrosine with known 
structures. Considering the position of fluorescent amino acid within the protein 
one can more easily understand the origins of the fluorescence changes. 
Proteins with single Trp residue often extensively studied by fluorescence due 
to the higher fluorescence of Trp accomplished by the wavelength shifts 
depending on the degree of amino acid solvent exposition. The tyrosine 
fluorescence exhibits no wavelength shifts and has much lower intensity. 
Nevertheless the structural and folding studies of proteins containing single 
tyrosine residues and no tryptophanes can be possible in some cases. The C-
terminal minicollagen cysteine rich domain (MCRD) and the first repeat of 
NOWA cysteine rich domain (NCRD1) are two fascinating examples of such 
fluorescent sensors. These domains are composed of only 24 and 25 amino 
acids accordingly. Both of them contain one tyrosine residue in position 17 for 
MCRD and position11 for NCRD1. Here we applied fluorescence 
measurements to monitor the MCRD and NCRD1 oxidative refolding. Such 
monitoring is possible due to the quenching of tyrosines fluorescence by nearby 
disulfide bonds in both peptides.  
The mechanism of fluorescence quenching by S – S bonds is not yet 
completely understood. Nevertheless several studies regarding this 
phenomenon have been performed over the last 40 years. First, Cowgill 
reported in 1967 that intrinsic fluorescence of tyrosine residue can be quenched 
by disulfide bonds (2). Already at that time Cowgill ascribed the diminished 
fluorescence to the vibrational dissipation of energy, not collisional quenching, 
hydrogen bond formation or FRET. Later studies (3) demonstrated the 
quenching of tyrosine containing peptides by oxidized dithiothreitol (DTT). 
Authors excluded collisional quenching mechanism based on the Stern - 
Volmer analysis and suggested the formation of complex between tyrosil and 
cysteine residues. Nevertheless Swadesh et.al. have not considered long range 
energy transfer as a quenching mechanism. Quenching mechanisms of 
tyrosine in polypeptides and proteins have been reviewed by Ross et al. in 
1992 (4). Considerable effort to understand a mechanism of tyrosine 
fluorescence quenching by disulfides has been made in this work but still there 
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was no conclusive picture. Later investigators assigned the quenching of 
tyrosine by the disulfide bonds to the frequency resonance energy transfer 
(FRET) where tyrosine considered as a donor and disulfide bond as a weak 
acceptor (5). Most of the studies devoted to the understanding of this 
quenching mechanism were done with model peptides. There are only few 
examples of the described phenomenon among the real proteins such as 
oxytocin and vasopressin. The conformation of these peptides has been 
studied by different methods including fluorescence study of intrinsic tyrosine 
emission (6, 7). Similar quenching effect was observed for the tryptophan 
containing proteins such as DsbA protein (8). Overall the number of proteins 
exhibiting disulfide quenching of the intrinsic fluorescence is very limited. In this 
regard the MCRD and NCRD1 peptides investigated in this chapter can serve 
as a nice model systems for protein folding studies.  
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Materials and Methods. 
 
Peptides synthesis and oxidation. 
The NCRD1 peptide was synthesized chemically with an ABIMED 
economy peptide synthesizer EPS 221 (Abimed, Germany) using standard F-
moc chemistry (described above). Pre-coupled resin was purchased from 
Novabiochem, Switzerland. Amino acids were from Alexis Biochemicals, USA 
or from Iris Biotech, Marktredwitz, Germany. Solvents and other chemicals 
were from Fluka (Buchs, Switzerland). The protein was purified using HPLC 
with a C-8 reverse-phase preparative column (Hibar, LiChrosorb®100 RP-8 
from Merck, Darmstadt, Germany). Protein purity was confirmed by nanospray 
mass spectrometry (2534.Da mass was found compared to calculated 2535.8 
Da) and analytical HPLC. 
Oxidation was carried out using the identical procedures. The lyophilized 
purified peptide was dissolved in 25 mM Tris/HCl, pH 6.0, containing 100 mM 
NaCl at a concentration of 0.05 mg/ml. Folding was allowed to proceed under 
N2 for 72 to 96 hours at 4 °C. Oxidation was induced by changing the pH to 
8.0-8.1 with saturated Tris, and the addition of reduced and oxidized 
glutathione (10:1 molar ratio) to a final concentration of 1 mM. The solution was 
exposed to air at 4 °C for four to ten days. Oxidation was stopped by the 
addition of trifluoroacetic acid to give a pH of 1.3. The oxidized peptide was 
purified by preparative HPLC. Mass spectroscopy of the oxidized peptide 
showed a molecular mass of 2528 Da. Theoretically calculated mass is 2529.8 
Da. 
 
NMR Data Collection 
NMR samples of chemically synthesized first repeat of NOWA cysteine 
rich domain (NCRD1) purified after oxidation were prepared in 95 % 1H2O, 5 % 
2H2O and in 100 % 2H2O, respectively. Samples had 1.5 mM concentration in a 
volume of 300 µl (Shigemi NMR microtubes) in 5 mM sodium phosphate buffer, 
pH 6.5 without further addition of salt. A set of standard homonuclear 
experiments similar to those described by Wüthrich (9) were recorded at 15°C 
with Bruker DRX 600 spectrometer. Data were processed with NMRPipe (10) 
and analysed with Sparky (11) to yield a complete proton assignment. Structure 
calculations were performed in CNS (12) with a standard simulated annealing 
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protocol. The coordinates and structural restraints have been deposited in the 
Brookhave Protein Data Bank under accession number XXX. Structure 
representations were generated with MOLMOL (13). 
Fluorescence Measurements 
Fluorescence spectra and kinetic measurements were recorded with an 
Aminco Bowman 2 spectrofluorimeter. All samples were temperature 
equilibrated at 25 o C before measurements. Samples were prepared in 50 µM 
peptide concentration. For reduction kinetic measurements Tri (2-carboxyethyl) 
phosphine hydrochloride (Mr 286.64) TCEP was used. The TCEP was bought 
from Sigma–Aldrich. In order to monitor oxidation kinetics completely reduced 
peptides (those monitored for reduction kinetics) were dialyzed in a 1 kDa 
dialysis membrane against 10 mM phosphate buffer of pH 5.5 to remove TCEP 
and prevent spontaneous oxidation. After dialysis samples were enriched with 
molecular oxygen, initial buffers of pH 5.5 were adjusted to pH 8.1 to induce 
oxidation, samples were sealed and measurements started immediately. 
Excitation wavelength was 275 nm, emission was recorded at 304nm 
corresponding to a maximum of single Tyrosine fluorescence. All fluorescence 
spectra were corrected for according buffer solutions.  
 
Partial reduction and alkylation 
Partial reduction of MCRD and NCRD1 peptides was carried out with 
TCEP in 5mM Citrate buffer at pH 5. After various time of incubation either at 
room temperature or at 37 o C reduction was stopped by direct injection of 
peptide solution on the analytical HPLC C18 or C8 columns. Intermediates as 
well as native and completely reduced fractions were collected and analysed 
with mass spectrometry. Desired intermediate fractions were alkylated by NEM 
(Sigma) for at least 1 hour at 37 o C. Alkylated material was analysed with mass 
spectrometry again. 
Foerster Theory for Frequency Resonance Energy Transfer (FRET). 
Latest studies regarding the mechanism of the tyrosine fluorescence 
quenching by disulfide bonds revealed that FRET is the main player of the 
game (5). A quantitative theory for singlet-singlet energy transfer has been 
developed by Theodor Foerster which assumes that the transfer occurs through 
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dipole-dipole interactions of donor and acceptor. Multipole and electron 
exchange interactions can also result in energy transfer. To obtain useful 
structure information from energy transfer, the measured efficiency must be 
related to the distance between the two fluorophores. FRET efficiency, E can 
be obtained by measuring the fluorescence intensities of the donor with 
acceptor, Fda and without acceptor, Fd: 
E = 1 – Fda / Fd 
FRET efficiency can also be measured using the lifetime of the donor in 
presence, Tda and absence of the acceptor probe, Td: These measurements 
were not done in the present study. The relationship between the transfer 
efficiency and the distance between the donor and acceptor, R is given by the 
equation: 
E = R06 / (R06 + R6) 
or  
R = R06 (1/E -1)1/6 
where Ro is the Foerster distance, that is, the distance at which energy transfer 
is 50% efficient. In other words, it is the distance where 50% of excited donors 
are deactivated by FRET. At Ro, there is an equal probability for resonance 
energy transfer and the radiative emission of a photon. The magnitude of Ro is 
dependent of the spectral properties of the donor and acceptor: 
Ro = [8.8x1023K2n-4QdJ]1/6 (Angstrom) 
where 
• K2 or kappa square = dipole orientation factor, a function of donor 
emission transition moment and the acceptor absorption transition 
moment (range 0 to 4, generally k2 = 2/3 is assumed)  
• Qd = fluorescence quantum yield of the donor in the absence of acceptor  
• n = refractive index of the medium which is generally assumed to be 1.4 
(range 1.33-1.6) for proteins.  
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• J = spectral overlap integral which represents the degree of overlap 
between the donor fluorescence spectrum and the acceptor absorption 
spectrum.  
The donor and acceptor must be within 0.5xRo -1.5xRo from each other. These 
measurements give the average distance between the two fluorophores. When 
measuring a change in distance, the result is a scalar and gives no indications 
of which fluorophore (donor and/or acceptor) moves. 
 
 
Results and Discussion 
 
NMR structure of the first repeat of NOWA cysteine rich domain NCRD1 
The solution structure of the synthesized NCRD1 peptide was determined by 
homo- and hetero-nuclear NMR techniques. The 25 amino acid peptide 
sequence is shown in bold and underlined on the figure 1 in comparison with 
the sequence of previously elucidated MCRD. Sequence specific 1H, 13C, and 
15N assignments were obtained from TOCSY and NOESY as well as 
heteronuclear HSQC and HMBC spectra acquired at natural isotope 
abundance. All cysteine residues appeared to be bonded in disulfide bridges as 
evidenced by their 13C shifts of 40 to 43.5 ppm (14). The disulfide pattern of the 
peptide was determined as Cys2 – Cys18; Cys6 – Cys 14 and Cys 10 – Cys19. 
This was derived from direct NOESY cross-peaks between Hβ atoms of the 
cysteine residues plus overall structure calculation with no disulfide restrains 
applied. The structural fold determined in assumption of open cysteines (Fig. 2 
lower ribbon) allowed the only possibility of disulfide bonds connectivity. Left 
upper part of the figure 2 represents all heavy atoms overlay of 10 lowest 
energy structures of NCRD1. All residues are displayed in dark green, except 
for cysteine side chains in yellow and proline 12 in red. Right part of the figure 
shows ribbon presentation in the same orientation. The structure of the NOWA 
cysteine rich domain is exclusively built up from a number of consecutive β-
turns: Ser7 – Cys10, Tyr11-Cys14 and Pro15-Cys18. The Pro12 (Fig. 1) 
imposes a β-turn topology on residues 11 to 14 due to its fixed phi angle of –60 
° and subsequently positions Cys14 and Cys6 in the close contact to form S-S 
bridge. Formation of this disulfide bond is a central feature of the NCRD1 
 
 
 
 
 
 
 
 
 
 
 
PCPPV   CVAQCVPTCPQYCCPAKRK – C-terminal MCRD 
  2         6     10    14   1819 
TCPSG   CSGDCYPECKPGCCGQVNLNAPVQPSGYT 
ACSQYPN CGLSCQSSCSQSCCQQNPYQPSVMSGTIVIQPNEQS 
VCPQHPG CSQHCAPRCSPQCCQQSMNSLYQPPQMS 
ACPQFPS CSPTCAPQCSQLCCQQSSMPLQMPQMP 
SCPQFPS CSASCAPQCSQQCCQQPSMSIQPLQIS 
SCPQFPS CSPSCAPQCSQQCCQQPSMPIQLPLMG 
SCSQMPG CSASCAPLCSQQCCQQQSMLQQSIMQQPMMMAQN 
PCSLQQPGCSSACAPACRLSCCSLGRMNLGR 
Figure 1. 
Sequence alignment of the C-terminal MCRD of minicollagen-1 and 8 NCRD 
domains of NOWA. The sequences of the MCRD with known structure (chapter 3) 
and NCRD1 are shown in bold. The sequence region of 8NCRD used for 
structure determination is underlined. Numbers indicate cysteine residues and 
correspond to the counting in the structures description. 
 
  
Figure 2. 
NMR structures of the first cysteine rich repeat of NOWA. Left upper part of the 
figure represents all heavy atoms overlay of the 10 energy minimized structures. 
All residues are displayed in dark green, except for cysteine side chains in yellow 
and proline 12 in red. The ten energy lowest structures are superimposed using 
the backbone atoms of residues 6-20. Disordered residues are 1-5 from the N-
terminus and 21-25 from C-terminus of the peptide. Most likely the N-terminus of 
the first cysteine rich repeat of NOWA continues the structural fold of the 
preceding protein domain. Right part of the figure shows the same view of the 
overlaid structures in ribbon representation. On the lower panel a ribbon 
presentation of the calculated structure without cysteine bridges is shown.  
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folding process. All prolines of the peptide are proved to be in trans 
conformation as evident from specific NOE distance information. In the full 
NOWA protein the NCRD1 follows the C-type lectin domain. All known CTLDs 
have conserved structural fold with a β-strand at the C-terminus. Proton 
chemical shifts of the Cys2 of NCRD1 adopt the characteristic β-strand values. 
Therefore N – terminus of the peptide is proposed to adopt the structure of 
preceding domain. In the isolated NCRD1 N-terminal structure is not stable. 
However the first disulfide bond Cys2-Cys18 is correctly formed. As it was 
discussed in the chapter 3 for the MCRD structure Cys2-Cys18 bond is formed 
later than Cys6-Cys14. Presumably in the NCRD1 it is the last one formed so 
that despite the flexibility of Cys2 the only possible partner Cys18 is found. This 
disulfide bond clasps the N- and C-termini of the NCRD1 structure. The third 
disulfide bond Cys10-Cys19 is more exposed to the C-terminal surface of the 
domains. 
  
Comparison of the NCRD1 and MCRD structures. 
Elucidated minicollagen and NOWA cysteine rich domains have 30 % 
sequence identity. The homology is restricted to the conserved cysteines and 
proline 12 residues. Pronounced structural similarity is observed for these 
peptides. In order to make common structural features of the NCRD1 and 
MCRD obvious the structures were superimposed on the Cα atoms of the 
cysteines (Fig. 3B). The RMSD of such superposition was 1.5 Ao. The disulfide 
pattern found for the NCRD1 is identical to that of the MCRD. Superimposed 
stereoview shows nicely colocalized disulfide bonds of two structures with the 
degree of solvent exposition comparable for each bond pair. Folding and 
disulfide pattern formation are often tightly coupled in cysteine rich peptides. 
The absence of significant secondary elements in the structural folds of both 
peptides indicates that folding and oxidation processes are almost synonymous 
here. The MCRD and NCRD1 structures built up from the turns with the only 
exception of the short α-helix in MCRD. Two turns are preserved: 11 – 14 and 
15 – 18. Upon superimposition of the Cα atoms of indicated residues the turns 
can be aligned at 0.2 Ao  (11-14) and 0.6 Ao  (15-18) RMSD accordingly. 
However orientation of these turns is slightly different in two structures (Fig 3B). 
Considering the goodness of the structural overlays 11-14 β–turn is the most 
 Figure 3.  
A, Stereoview of the NCRD1 structure represented in the same 
orientation as on figure 2 in ribbon presentation. Cysteines and 
disulfide bonds are shown in yellow and Pro12 is indicated. Disulfide 
bonds are Cys2-Cys18, Cys6-Cys14 and Cys10-Cys19. 
B, Stereoview of overlaid MCRD and NCRD1 structures. Blue ribbon 
is MCRD and green ribbon is NCRD1. Disulfide bonds indicated in 
yellow for MCRD and in red fir NCRD1. Structures were 
superimposed on cysteines CA atoms. RMSD is 1.5 Ao. 
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conserved feature of the fold. Formation of the central Cys6 – Cys14 bond is 
determined by this turn and induced by conserved Pro12 residue.  
A major structural difference observed in the N-termini of the peptides. 
The N-terminal α-helix followed by inverse γ- turn of the MCRD are replaced by 
a flexible Thr1 - Gln5 sequence followed by a β–turn Ser7 – Cys10 of the 
NCRD1. This is proposed to be dependent on the preceding structural folds. In 
case of MCRD the preceding structure is polyhydroxyproline II helix while in 
case of NCRD1 it is presumably a β– strand. Remarkably in both peptide 
structures first residues adopt conformation of the corresponding preceding 
secondary structure. Therefore only conserved β– turns together with defined 
disulfide pattern must be considered as signatures of the new fold. 
 
 
 
Partial reduction and alkylation of MCRD. 
In order to approach the problem of minicollagen/NOWA intermolecular 
disulfide reshuffling we performed partial reduction experiments of the cysteine 
rich domains. Two equally accessible disulfide bonds Cys2 – Cys18 and Cys 
10 – Cys19 can potentially undergo disulfide isomerisation. Partial reduction of 
MCRD peptide was performed with TCEP - a reducing agent which allows 
reduction to proceed at the low pH. Sample acidification prevents scrambling of 
disulfide bonds. MCRD peptide was incubated with different access ratios of 
the reducing agent for different times. Results (Fig. 4) revealed the presence of 
three peaks one of which was identified as native MCRD and the others 
represented completely reduced form and an intermediate. All fractions were 
collected and alkylated in order to distinguish between different intermediates. 
Alkylated material was characterized by mass spectroscopy and identified an 
intermediate peak as the one containing two intact disulfide bonds (2S-S). It 
has to be mentioned that reduction of MCRD peptide was rather slow process 
although completely reduced form appeared already at the time when 2S-S 
intermediate did. This fact led to the insufficient peaks separation. Native, 
reduced and intermediate peptide were simultaneously presented in all 
collected fractions. Variations of the reduction time, HPLC run parameters or 
columns (C8 or C18) did not yield a satisfactory result. Therefore further 
determination of the particular reduced disulfide bond in the 2S-S intermediate 
 Figure 4 
High pressure liquid chromatography run of the partially reduced MCRD 
peptide. There are native, completely reduced and 2S-S intermediate 
identified which indicated by arrows. Upper panel represents absorption at 
280 nm, lower panel is monitoring of the fluorescence signal at 350 nm.   
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is possible but complicated. There are two possibilities in this direction: 
LC/MS/MS study and the introduction of charges via alkylation with 
Iodoacetamide with subsequent fraction separation on the ion exchange 
column. The alkylation process with Iodoacetamide requires pH 8 or higher that 
can lead to disulfide reshuffling and complicated picture of the intermediates as 
a result. However following one of these approaches should reveal the most 
susceptible disulfide bond i. e. the most prominent for intermolecular 
isomerization.  
Interestingly comparison of the fluorescence and absorption signals from 
the HPLC peaks is not conclusive on the first glance. The most pronounced 
absorption peak at 280 nm corresponding to the native peptide is at the same 
time the least pronounced among the fluorescence peaks. The opposite is true 
for the reduced peptide peaks. The absorbance of this fraction is the least when 
fluorescence is the most. As concerned the 2S-S intermediate peak it is the 
only one exhibiting comparable absorption and fluorescence signal (Fig.4). 
Similar effect was observed for the partial reduction of NCRD1 peptide (data 
not shown). These observations were completely reproducible therefore we 
excluded an artefact interpretation. Further measurements clearly 
demonstrated that observed phenomenon is due to the quenching of the 
tyrosine fluorescence by the intact disulfide bond.  
 
Quenching of tyrosine fluorescence by disulfide bond. Kinetics of 
reduction and oxidation 
Fluorescence spectroscopy was utilized to investigate the reductive 
unfolding and oxidative refolding of the MCRD and NCRD1. The solvent 
environment of single tyrosine in these peptides was probed in the native and 
reduced forms. Figure 5 shows the results of the addition of 10 mM TCEP to a 
50 µM solution of MCRD and NCRD1 followed by incubation during 2 hours at 
37 °C. Before measurements all samples were equilibrated in temperature to 
25° C. The fluorescence spectra of MCRD and NCRD1 alone were low in 
intensity and maximum were observed at 304 nm for both peptides as expected 
for Tyr – containing proteins. Addition of TCEP to the MCRD and NCRD1 
resulted in a large and significant increase in the fluorescence intensity in both 
cases (~3-fold for MCRD and ~2 – fold for NCRD1). Quantum yields of the 
peptide fluorescence were determined by comparison with the fluorescence of 
 Figure 5 
 Effect of Tri (2-carboxyethyl) phosphine hydrochloride (TCEP) on the fluorescence 
of single tyrosine in MCRD (A) and NCRD1 (B) peptides. Fluorescence spectra of 
minicollagen cysteine rich domain (MCRD) in 50 µM in the presence and absence 
of 10 mM TCEP shown on figure A. The same for the first repeat of NOWA cysteine 
rich domain (NCRD1) represented on figure B. The native peptides have very low 
fluorescence intensity (0.05 and 0.04 quantum yield for MCRD and NCRD1 
accordingly) due to quenching of the Tyr residue by the neighboring disulfide, an 
effect removed upon reduction by TCEP. 
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tyrosine solution in the same molar concentration. Quantum yield of the MCRD 
revealed 0.052 and 0.13 in native and reducing conditions accordingly. The 
tyrosine fluorescence of NCRD1 exhibited even lower quantum yields of 0.042 
in the native form and 0.087 in the reduced form. Reduced fluorescence of 
NCRD1 compare to MCRD indicates the presence of additional quenching 
mechanism unrelated to the reduction process. However quenching of Tyr 17 in 
the MCRD peptide is more effective (EMCRD = 0.67) than quenching of Tyr 11 in 
the NCRD1 (ENCRD1 = 0.44). Indicated efficiencies of the fluorescence 
quenching were determined in terms of frequency resonance energy transfer 
using Foerster theory described in materials and methods section of this 
chapter. Implying that quenching of tyrosine fluorescence by disulfides 
governed by frequency resonance energy transfer (FRET) one can speculate 
that quenching effect is dependent on the distances separating according 
tyrosines and disulfides and on the mutual dipole orientation of donors 
(tyrosines) and acceptors (disulfide). The shortest distances from the tyrosine 
residues to the disulfide bonds are indicated in the stereo view for MCRD and 
NCRD1 structures on the figure 6 and figure 7 accordingly. Potential 
donor/acceptor pairs are Tyr17/Cys2 – Cys18 in MCRD and Tyr11/Cys6-Cys14 
in NCRD1 although other disulfides may also participate. 
Kinetics of reductive unfolding and oxidative refolding of both peptides 
were studied by tyrosine fluorescence quenching. Figure 8 summarized the 
results of these experiments. Reduction and oxidation kinetics of MCRD and 
NCRD1 were fitted with mono-exponentials. This fact suggests a simple 
quenching mechanism most probably controlled by a single disulfide bond in 
both cases. The NCRD1 revealed slower reduction rate constant 3.4 * 10-4 s-1 
compare to 4.3 * 10-4 s-1 for the MCRD. On the other hand oxidation had 
happened faster in the NOWA domain (3.9 * 10-4 s-1) compare to the 
minicollagen peptide (1.7 * 10-4 s-1). In the other words half oxidation time of the 
MCRD was 90 minutes when that of the NCRD1 was only 40 minutes. The 
values calculated for the MCRD peptide are in good agreement with 80 minutes 
of half oxidation time measured by monitoring of NMR signal of Tyr17 and Val5 
amide protons (chapter 3) (15). Oxidative folding of the NCRD1 was not studied 
with NMR. However the following question has to be answered: “Where the two 
times difference in the oxidation rates of the peptides with similar structures 
arises from?” A simple answer is proposed. Assuming that tyrosine quenching 
 Figure 6 
Stereo view of the MCRD structure in ribbon presentation with the indicated 
shortest distances between tyrosine 17 shown in green and disulfide bonds shown 
in yellow. Distances are shown in red by dashed lines. Following distances 
correspond to: 3.44 A° – Tyr17/Cys2-Cys18; 8.82 A° - Tyr17/Cys6-Cys14; 10.90 A° 
- Tyr17/Cys10-Cys19. 
 Figure 7 
Stereo view of the NCRD1 structure in ribbon presentation with the 
indicated shortest distances between tyrosine 11 shown by dashed lines 
and disulfide bonds shown in yellow. Following distances correspond to: 
3.13 A° – Tyr11/ Cys6-Cys14;  
6.98 A° - Tyr11/ Cys2-Cys18;  
10.8 A° - Tyr17/Cys10-Cys19. 
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is controlled by single disulfide bond we consider pairs of Tyr17/Cys2 – Cys18 
in MCRD and Tyr11/Cys6-Cys14 in NCRD1. It was discussed several times 
that Cys2 – Cys18 bond is more susceptible for reduction than Cys6 – Cys14. 
Subsequently this bond opens first during unfolding and closes last during 
folding of the peptides. This assumption immediately explains the observed rate 
constants of quenching kinetics. Represented reduction and oxidation kinetics 
reflect the rates of reduction and oxidation of the Cys2-Cys18 bond in MCRD 
and the Cys6–Cys14 bond in the NCRD1. The difference in the kinetic rates is 
therefore due to the fact that central disulfide bridge opens later and forms 
earlier than two others. Two other potential donor/acceptor pairs Tyr17/Cys6-
Cys14 in MCRD and Tyr11/ Cys2-Cys18 in NCRD1 would exhibit exactly the 
opposite behaviour. 
To study the peptides oxidative folding in details one should analyse the 
intermediates isolated at the certain times of the oxidation and (or) reduction 
kinetics. However oxidative refolding of both peptides is fast process leading to 
the formation of the correct structure at the high yield as evident from the NMR 
data (15). Moreover the MCRD peptide showed no unfolding transition neither 
for temperature heating up to 120 °C nor for the titration with chemical 
chaotropes up to 8M of urea or 6M of guanidine chloride. The MCRD unfolding 
has been monitored using CD and Calorimetry measurements (data not 
shown). In the 8M urea the peptide exhibited native 1D NMR spectrum (15).  
In summary, folding of the investigated peptides is completely determined 
by disulfides formation and follows a certain direction without populating the 
wrong intermediates. The MCRD and NCRD1 are interesting models for 
general protein folding studies due to the disulfide quenching of tyrosine 
fluorescence controlled by two different S-S bridges. 
 
 Figure 8. 
Fluorescence quenching effect applied for reduction (A) and reoxidation (B,C) 
kinetics measurements of the MCRD and NCRD1. Measured fluorescence data 
shown by symbols. Lines correspond to the kinetics fit with single exponentials. 
Reduction rate constants from the according fitting curves are:  
3.4 * 10-4 s-1 for the NCRD1 (red)  
4.3 * 10-4 s-1 for the MCRD (green). 
Oxidation rate constants are: 
1.7 * 10-4 s-1 for the MCRD 
3.8 * 10-4 s-1 for the NCRD1 
NCRD1 
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